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INTRODUCTION 
In the course of the battle between the living 
mammalian organism and the external environment, the animal 
body must make constant adjustments to meet stress situa -
tions and to maintain the homeostasi's of the milieu 
i nterieur. The glands of internal secretion play an im-
portant role in the se adjustments. Of the endocrine 
secretions, the hormones of the adrenal gland, bot h the 
cortex and the medulla are of paramount i mportance. 
In an evaluation of the metabolic alterations to 
stress situations,. it is necessary to realize that the 
endocrine gla nds are intricately regulated by a system of 
checks and balances. 'rhis system is most readily seen in 
the endocrine regulation of carbohydra te metabolism. It 
is obvious that the forces involved in maintaining a 
homeostatic level of carbohydrate metabolism can act in 
only two dimensions, increase or decrease, and only when 
these forces are at equilibrium, i.e., rate of production 
equals rate of destruction or i~nobilization, can a homeo-
static situation occur. It is interesting to note that 
the individual endocrine glands not only affect carbohy-
drate metabolism by the direct action of their respective 
hormones, but in addition t hey exer t an effect by influenc-
ing either directly or reflexly the activity of the other 
endocrine glands . Thus,_ the adrenal gland, the pituitary, 
and the thyroid act synergistically to increase the blood 
glucose while the islets of Langerhans act to decrease the 
blood glucose. It should be understood that the effect of 
artificial stimulation or injection of an individual hor-
mone will, in the intact organism, be governed by the exist-
ing endocrine balance in that organism at the time of 
stimulation. 
In the course of the past century, a great deal of 
emphasis has been placed upon the evaluation of the role of 
the adrenal gland in the control of body metabolism in the 
normal ·individual as well as in the individual during a 
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stress situation . This gland is interesting in that it is 
regarded anatomically as a single gross structure, yet physi-
ologically and histologically there are two units, each 
capable of functioning quite independently of the other and 
affecting each other only by way of another gland, the 
anterior pituitary, or by changes in tissue metabolism (103a). 
Therefore, when considering, for example, the effects in 
an intact animal of epinephrine administration of stimulation, 
it is necessary to remember that in addition to the actions 
of epinephrine, one is bound to reveal some of the effects 
of the adrenal cortical hormone, since the former will 
stimulate secretion of the latter by stimulating the anterior 
pituitary to secrete adrenocorticotropin. The beauty of the 
s_ynergism of activity between the adrenal cortex and the 
adrenal medulla is readily exemplified in their effects on 
carbohydrate metabolism. 
Under conditions of general body stress, the 
adrenal medulla is stimulated, either directly or reflexly 
to secrete its hormone, epinephrine. It is the purpose of 
this study to evaluate the role of epinephrine and its 
action on carbohydrate metabolism. The initial body ad-
justment to stress sacrifices the homeostasis of carbo-
hydrate metabolism in order to meet the higher energy 
requirements of the organism. However, this interruption 
in the homeostasis is quite transient, and a new adjustment 
occurs at a higher level if stress is continued and its 
former level if it ceases. Ever since Blum 's experiment 
in 1901 ( 11) shm'ling that epinephrine injected into a dog 
produced glycosuria, there has been an overwhelming number 
of reports in the literature which have offered theories 
and proofs of the mechanism of action of epinephrine in its 
effect on carbohydrate metabolism . 
It would be well, in this introduction, to con-
sider some of the fundamentals of carbohydrate metabolism 
and to define a few of the terms which will be used in 
the course of this study; for a misuse of terms is one of 
the reasons for the confusing results which are seen. 
The available evidence makes it rather clear that 
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in the postabsorptive mammalian individual the only source 
of blood glucose is the liver. The lev~l of blood glucose 
is basically regulated much the same as the level of water 
in a sink with a faucet and a sewer drain. One could cause 
the level of water to rise by four methods. First, the 
inflow from the faucet could be increased without increasli1g 
the outflow from the sewer drain; second, the outflow from 
the sewer drain could be decreased '\'lithout increasing the 
rate of inflow from the faucet; third, both the inflow and 
the outflow could be increased with the inflow increasing 
faster than the outflow; ar0 finally the inflow could in-
crea se and the outflow decrease in all proportions to each 
other. Exactly the opposite of the abov~ four methods 
would cause the level of the water to decrease and only 
when the inflm'l from the faucet is in dynamic equilibrium 
with the outflow from the sewer drain will the level of 
the vmter remai n constant. The analogy to the level of 
blood sugar will be realized if one substitutes the liver 
supply of glucose for the faucet and the uptake of glucose 
by the tissues as the sewer drain (108a). 
The liver stores its glucose as glycogen. Under 
a given stimulus, this glycogen is hydrolyzed and phos-
phorylated forming a hexosemonophosphate ester, glucose-
1-phosphate which is isomerized to glucose-6-phosphate, the 
Cori ester. Under the action of a hexosephosphorylase, 
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:this ester is split into_ phosphoric acid and glucose. It 
is generally considered that this reaction occurs within 
the liver cell, and the process is known as glycogenolysis. 
It is important to remember that this process is quite 
reversible, and as such it provides a means for glucose to 
enter the liver cell, and under the action of hexokinase 
be esterified with phosphate and undergo the transformation 
to glycogen. The liver glycogen can be formed, in addition, 
from carbohydrate metabolities, such as lactic acid, by 
an enzymatic conversion of two and three carbon fragments 
to glycogen. This formation of glycogen from glucose and 
carbohydrate metabolities is known as glycogenesis. How-
ever . liver glycogen can also be formed from non;,_carbohydrate 
precursors, a process known as glyconeogenesis. The ~ain 
precursors for this process are proteins, which in the course 
of their metabolism are broken down to two and three carbon 
fragm~nts. These fragments enteringthe liver cell a:re ex-
posed to a number of enzyme systems, and are finally converted 
to glyco gen (26, 43a, 6la , l08a). 
The muscle glycogen, which comprises the greatest 
part of the tissue glycogen is unable to form blood glucose. 
Like the liver glycogen, it is esterified with phosphate, 
then isomerized to form the Cori ester, the beginning of the 
process of glycolysis. However, follo\ving this, the ester 
undergoes a series of transformations, passing through a 
!lUmber of acid forms, finally ending as pyruvic acid. 
This entire process is anaerobic, and if it continues in 
an anaerobic state, lactic acid will be formed . In the 
presence of oxygen, the organic acid enters an oxidative 
cycle , which is known as the Krebs' cycle, and finally is 
broken down to carbon dioxide and water. This entire 
process, the transformation of glycogen to its final end 
products, lactic acid, carbon dioxide, and wat er is an 
exothermic reaction, and is believed by most physiologists 
to provide the ultimate energy for muscular contraction 
(2 6 , 43a, 6la). This process of the degradation of glucose 
to carbon dioxide, water, and l a ctic acid , together with 
the rocess of glyco genesis in both l iver and muscle, we 
shall define as glucose uti l ization. 
To complete the carbohydrate cycle, the lactic 
acid is carried by the blood stream to the liver where it 
is converted, as described above, t o .liver glycoge n . In 
the mammalian organism, the muscle is unable to convert 
lacti c acid to muscle glycogen. How then does the muscle 
repleni sh its glyco gen? A process exactly the same as 
occurs in the liver also occurs in the muscle; i.e., muscle 
glucose and phosphoric acid are esterified under the action 
of hexokinase to form the Cori ester, glucose-6-phosphat e . 
This phase of glucose metabolism, the removal of glucose 
from the interstitia l fluids by the tissues, and its 
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phosphorylation, from now on will be referred to as the 
uptake of blood sugar to distinguish it from gl ucose uti-
l ization, which refers to the combustion and catabolism 
of gl ucose as well as glyco gen formation from hexosemono-
phosphate. The Cori ester can undergo two main trans -
fo r mations. It can either be isomerized to glucose-1-
phosphate, and then be converted to glycogen, or it can 
be broken down to the various acids finally forming ca rbon 
dioxide and water. In the literature , the amount of 
glucose uptake is called glucose utilization. If this were 
true , i n isolated tissue studies, all of the glucose re-
moved from the medium should be accounted for in t erms of 
glycogen synthesis and carbon dioxide and lactic acid 
format ion. However, the results of previous studies (64, 
115, 121) as well as this study have been unable to support 
the validity of this hypothesis. Actually, it has been 
shown that it is possible for the isolated muscle to store 
hexosernonophosphate under certain conditions, i.e., while 
under the influence of epinephrine (64, 115 , 151). There-
fore , it is believed to be of paramount importance to 
separate the two phases, glucose uptake and gluco~e uti-
lization, in order to interpret the mechanism of epi-
nephrine activity in carbohydrate metabolism. 
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THE EFFECT OF ADRENERGIC BLOCKING DRUGS ON EPI NEPHRINE-
I NDUCED HYPERGLYCEMIA IN HABBITS 
INTRODUCTION 
A majority of the available adrenergic blocking 
drugs are lcnovm to diminish or block many of the excitatory 
effects of epinephrine, although the positive chronotropic 
effect of epinephrine upon "che myocardium is not knovn1 to 
be blocked by any adrenergic blocking drugs. Since an 
excellent extensive revievv on the pharmacology of adrenergic 
blockade has been published by Nickerson (92), no attempt 
will be made to review this subject in this thesis. In 
view of the ability of the ad~energic blocking drugs to 
inhibit so many of the physiologic effects of epinephrine, 
it seems important to know the effects of these drugs on 
hyperglycemia produced by exogenous epinephrli1e. Data 
concerning the effect of these drugs upon the metabolic 
effect of epinephrine are limited in quantity and scope. 
If adrenergic blocking drugs could be proved to block some 
specific phase in carbohydrate metabolism, they would be 
useful research tools for investigating the mechanism of 
epinephrine-induced hyperglycemia as well as other problems 
in carbohydrate metabolism. Consequently, the follov-ring 
experiments \vere made to determine whether or not some of 
the potent adrenergic blocking drugs recently synthesized 
are capable of blocking epinephrine-induced hyperglycemia. 
9. 
11/iETHODS 
Adrenergic blocking drugs were injected into male 
albino rabbits in order to determine their influence on 
hyperglycemia induced by epinephrine injected 30 minutes 
after the test drug. All agents \vere i njected intravenously 
in order to remove the influence of the rate of absorption. 
All experiments vvere performed on a series of 35 
rabbits which when not in use \'Vere kept in individual vlire 
cages, and fed Purina Rabbit Pellets and cabbage. The 
animals were fasted for 18 hours p~ior to the test, and 
water was supplied ad libitum. They were acclimatized to 
the experimental procedures (sitting in rabbit boxes, in-
j action procedures, and vlithdrawal of blood ) at least twice 
before any data were tabulated. No agent was tested more 
than once in ·the same rabbit, and the experiments v-;ere so 
designed that on any one day a number of compounds and 
saline controls were tested . The animals were pl aced in 
individual rabbit boxes which 1...rere uncovered except when 
injections or blood withdravvals were made. Blood samples 
\vere taken by cutting the ear vein and collecting a sar~ple 
of freely flowing blood. 
The procedure consisted of i n jecting the a gent to 
be tested over a one minute period. Thirty minutes later, 
a blood sample vvas taken and epinephrine 1.vas injected. 
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DosE-RESPONSE CURVE of epinephrine-induced hyperglycemia in rabbits. 
,Blood samples were collected at 5 , 10 , 15, 20, and 40 minutes 
following the injection. The blood sugars were then deter-
mined . by the Folin- Malmros micromethod (41). 
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A standard dose of 4 gamrna/kg. of pure 1-epinephrine~:< 
in a vo lume of 0.5 ml. was injected at a steady rate during 
30 seconds. This dose was selected on the basis of the dose-
res ponse curve shown in Figure 1. Six doses of epinephrine 
\-vere injected into a series of rabbits, and the blood sugar 
was measured at five minute intervals following the injection. 
A total of s~ven rabbits were tested with each dose. There 
was no significant difference betv-Teen 4, 8, and 16 gamma/kg. 
while with 32 gamma the curve rose sharply, suggesting that 
the dosage level produced its effect by means of another mecha-
nism. This curve is in close agreement with the one described 
by Eadie (34). The dose of 4 gamma/kg. was reported (15) to 
be just within physiologic range. Furthermore, doses of a 
similar magnitude have been reported to induce a moderate 
hyperglycemia in rabbits (34), and cats (55). Although a 
saline injection did not have any effect on the fasting blood 
sugar level over a period of 180 minutes , the injection of a 
standard dose of epinephrine induced a prompt rise which 
reached its maximum at 15 minutes and returned to normal in 
40 minutes . The magnitude of the rise in blood sugar with 
this dose was surprisingly consistent, since it varied only 
from 27 to 40 mg./100 ml. of blood in 60 untreated rabbits. 
~~Throughout this dissertation the dose of epinephrine is 
g iven in terms of pure 1-epinephrine base. 
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TABLE 1 . 
EFFECT OF ADRENERGIC BLOCKING DRUGS ON EPINEPHRINE-INDUCED 
HYPE RGLYCEMIA 
-· --·- ·-
--- -- ··· . 
LEVEL MEAN LEVEL 
MEAN I 
NO. OF MEAN PR E PARATH> :-< T EST EU 1 'DOSE I.V . RABBITS 30 MINUTES ! 15 lUNUTES RISE a AFTER AFTER EPI, I 
DRUG I 
--
- -- --- - ----- ... 
--
mg/ kg. mg % mg. % mg. % 
- j--
2 
3 
4 
5 
6 
7 
8 
9 
IO 
II 
1 
: Saline, control for drugs I to 9 r m i. II !03:::1:: 7 I40:::I:: II 37:::1::4 
Sali ne, control for drugs Io, II r mi. I4 I OI :::!:: 3 132:::!:: 4 3 1:::1::4 
Dihydroergocornine (Sandoz- 0. I 6 10 7:::!:: 3 II0:::!:: 2 3:::1:: 2 
DH0-I8o) .. 
E thy l-2-chloroe thy l-2-ortho- 2 6 !12:::1:: 3 . !14 :::1:: 5 3:::1:: 3 
benzy lphenoxyethy !amine 
HCI (Eli Li lly- o4679) 
r -Pheny i-2N-methy!benzy l- 2 . 5 6 ro8:::!:: 2 II0:::!:: 3 2:::1::2 
arn in oe thy lchloride H CI (Eli 
Lilly-o8353) 
N -9-Fluoreny l-N-ethy l-2 2 6 107:::1::7 I2I:::I::9 14:::1::4 
chiore thy larnin e H CI (P a rk e, 
D a vis SY-21 ) 
I-N a ph thy lrnethy le thy l- 2- 2 6 II0:::!::5 124:::1::5 14:::1:: 3 
bromoe thy la mine H B r I 
' 
(Park e, D avis SY 28) ' 
3-(N -E thy 1-N-2-chloro-ethyl) 5 6 I I 2:::!::6 !26:::!::8 14:::1:: 4 
aminoethy l thia naphthene 
HCI (Eli Lilly - o8 r25) 
2-(2-B ipheny ly loxy)-2' -ch i oro- 5 6 ll 2:::!::4 !29:::!:: 6 !7:::1:: 3 
triethylamine H CI (Parke, 
Davis SY-8) 
N -Ethy!-N-(2-chloroethyl) 10 4 108:::!::6 I 45:::!:: 9 37:::1::5 
benzhydrylamine HCI 
(Parke, Davis SY-2) 
3 (N-Methy l-N-2-chloroethyl)- s 4 I IO::f:7 I49 :::!:: 6 39 :::1:: 4 
aminomethyl thianaph thene 
HCJ (Eli Lilly- o8 r 24) 
r-Naphthylme thylethyl-2 4 5 102:::1:: 3 132 :::1:: 2 30:::!::1 
hydroxyethy lamine HCI 
(Parke, Davis SY-73) 
I 
I -Phenyl-2N -methy l-benzyl- 5 5 103:::1::3 I34:::!::3 31:::1::4 
arninoethanol HCl (Eli 
Lilly- o 2o 74) I 
1 Drugs I to 9 were tested in a grou p of 20 rabbits . Drugs ro and II, in ro rabbits. 
%oF 
CONTROL 
R ISE 
r oo 
roo 
8 
8 
5 
38 
38 
38 . 
46 
IOO 
105 
98 
I OO 
2 Epinephrine was injected i .v. in a d ose of 4 1-1g/ kg. over 30 seconds 30 minutes after the i.v. 
administration of the b locking agent. 
a Statistical comparison of group data for each of the compounds n o. I to 7 with control data 
yield s a P value: < o .oi. 
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H.ESULTS 
The effects of drugs on epinephrine-induced hyper-
glycemia are tabulated in Table 1. The administration of 
an adrenergic blocking drug did not change the time of 
m<:.uimum rise in the hyperglycemic curve. Therefore, only 
the rise occurring at 15 minutes after the injection of 
epinephrine is herein reported, although as mentioned above 
blood ·samples at 5, 10, 15, 20, and 40 minutes w·ere obtained . 
Each agent was tested for its effect on the fasting blood 
sugar level in 3 rabbits and in no case w-as "Ghere any 
significant change over a. period of 150 minut es. 
In most cases the dose of adrenergic blocking 
drug selected for use \vas several times the dose required 
to reverse epinephrine-induced hypertension, since in these 
experiments we are probably dealing with only the excitatory 
phase of adrenergic activity, while in the blood pres~::;ure 
response both the exci tutory a:n.d inhibitory phases are 
present, and a slight reduction in the excitatory phase is 
exaggerated by the presence of the inhibitory phase. 
Dihydroergocornine. The pharmacology of dihydro -
ergocornine ( DH0-180) he:1 s been studied by Rothlin (102), 
1vho found this agent to be a potent blocking agent as 
measured by the effect on hypertension induced with epi -
nephrine . In his experiments t o test the effect of the drug 
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on epinephrine-induced hyperglycemia, both the DH0-180 and 
epinephrine 1r1ere injected subcutaneously. His results show 
that hyperglycemia was diminished or blocked. In this 
study his experiment has been repeated, using the same dose 
of DH0-180, but injecting intravenously as described above. 
It is in'ceresting to note that in each of the six: rabbits 
tested this agent produced ar:1 effective blockade of the 
bl?od sugar rise in a dose which is smaller than the one 
required to consistently reverse epinephrine hypertension. 
One wonders if this means that the compound has a selective 
action on the liver cells. As shall be seen in a subsequent 
part of this study there is further evidence in support of 
the validity of this suggestion. 
The remainder of the compounds tested belong to a 
series of 2-haloalkylamines. It has been found (94) that 
the ethyl homologues of this series have a greater adrenergic 
blocking activity than the methyl homologues, and if the 
halogen is replaced by an hydroxyl group the resulting com-
pound loses its blocking ability (78, 79 , 80 , 94). Several 
ethyl homologues have here been tested for their effect on 
epinephrine hyperglycemia. 
2-0r'chobenzylphenoxyethyl. Compound 2( Table 1) 
v1as . previously reported ( 65) to be a potent adrenergic 
blocking drug. In the present experiments a dose somewhat 
larger than that required to reverse epinephrine hypertension 
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in dogs produced a complete .blockade of induced hyperglycemia, 
in rabbits. 
1-Phenyl-2-N-lVIethylbenzyl. Preliminary erperiments 
(20) have shown that compound 3 will reverse epinephrine 
hypertension in the dog in a dose of 2 mg. /kg. Follo~1ing 
injection of 2 .5 mg ./kg . of this agent, there i:vas no change 
in the fasting blood sugar level in response to epinephrine . 
As v'lill be sho\m in the next series of experiments i n this 
study, this compound also reduced the hyperglycemia resulting 
from an infusion of epinephrine in dogs. VJhen the halogen 
of this compound was replaced by an hydroxyl group (Compound 
11) the resulting agent even in twice that dose did not 
affect the hyperglycemia in rabbits, indicating that the 
presence of the halogenated ethylarnine group is required for 
the blockade of hyperglycemia as well as the pressor response 
of epinephrine. 
9-Fluorenyl. Compound 4 has been found to be among 
t h e most potent of adrenergic blocking drugs (71, 78). It is 
a s pecific a gent, antagonizing onl y the effects of epinephrine 
and some of its congeners. This compound in a dose of 2 mg ./kg . 
effectively reduced the induced hyperglycemia in rabbits and 
as we shall see later, in dogs , although a complete blockade 
dj_d not occur. 
1-Naphthylmethyl. Previous reports . have shm.·m that 
Compound 5 is a poten"c epinephrine antagonist ( 79, 113), 
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although not s pecific in its adrenergic blocking activity, 
since it is a potent antihistaminic ( 7c5, 79 , 113) . This 
compound in a dose of 2 mg ./kg . produced the ;:;arne reduction 
in hyperglycemia as Compound 4. VJhen the halogen was re-
placed by an hydroxyl radical (Compound 10) the resulting 
agent lost all of its effect in antagonizing the epinephrine 
toxicity in mice (79 ). This gives further support to the 
belief that the abili'cy to inhibit the hyperglycemic effect 
of epinephrine is r elated to the ability to inhibit the 
other effects of epinephrine . 
Methylthionaphthalene . Compound 6 is not as potent 
a s the above compounds in its adrenergic antagonism, as 
measured by reversal of the pressor res ponse to epinephrine 
(20). It required a dose of 5 mg . /kg . to eff ect a reduction 
of t l1 e induced hyperglycemia e quivalent to that obtained by 
Compounds 4 and 5. 
The methyl homologue o£' this compound (Compound 9) 
was weakly active in causing reversal of epinephrine hyper-
tension (20), and had no effect on the induced hyperglycemia. 
Thus, it is again noted trv::tt an agent which loses its ad-
re:..Iergic blocking activity also loses its ability to reduce 
epinephrine-induced hyperglycemia. 
2-Biphenylyloxy . It has been reported that Com-
pound 7 is less potent than Compounds 2 to 5 when i'Gs 
blocking of adrenergic activity is measured (80). This 
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agent, like Compound 5, is . not only an adrenergic blocking 
drug, but also shows antihistaminic activity. Like Com-
pound 6, a dose of 5 mg ./kg . only reduced the hyperglycemi a . 
Thus a gain t,h ere is evidence that adrenergic blocking drugs 
of low potency are not highly effective in diminishing 
epinephrine-induced hyperglycemia. 
Benzhydryl. Compound 8 has b een described a s 
being of the same order of adrenergic blocking potency as 
Dibenamine (78 ). Dibenarnine, itself, has been tested ( 93) 
(although the injections were made subcutaneously), and 
f ound to be vvithout ef f ect in reducing induced hyperglycemia. 
However, further experiments (49) demonstrated that if the 
numbers of animals lvere increased, and a cross-over type of 
experiment vms employed, a statistically significant decrease 
in the epinephrine-induced hyperglycemia could be demons~rated. 
The dose of test drug employed in those experiments vms large. 
VThen Compound 8 i-vas used in a dose of 10 mg./kg ., it f ailed 
to elicit a si gnificant reduction in hyperglycemia. 
Thus, Compounds 2 to 5 v-ih ich are t he most potent 
members of the ethyl homologues of the 2-haloaD{ylamine 
series succeeded in blocking or markedly reducing the hyper-
g l ycemic response to 4 gamma/leg. of epinephrine. It required 
almost twice the dose of the less potent homologues (Com-
pounds 6 and 7) to effect an equivalent blockade, and the 
i;v eakest member of the seri_es, (Compound 8) \vas without ef f ect. 
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The methyl homologue ( Compound 9 ) and the non-halogenated 
derivatives ( Compounds 10 and 11) wh ich are either devoid 
of the ability to reverse epinephrine hypertension or show 
a very weak adrenergic antagoni sm , were also without effect 
i n reducing epinephrine-hyperglycemia. 
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D.ISCUSSIQN 
As early as 1912, 1•Iiculicich ( 88) demonstrated 
that ergotoxin reduced the hyperglycemia and glycosuria due 
to subcutaneous injection of epinephrine in the rabbit. How-
ever, since that time, other adrenergic blocking drugs have 
been shown to be effective when used in the rabbit. 
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In 1929, Hanson (58) studied the effect of yohimbine 
on epinephrine-induced hyperglycemia. The rise in blood sugar 
was elicited by a subcutaneous injection of 0.1 mg./kg. in 
rabbits. This rise was completely suppressed by an intra-
venous injection of 1.5 mg. of yohimbine per kg. of body 
weight. Whereas the control blood sugar rose from 115 to 
315 mg. % in 1.5 hours after epinephrine injection, the rise 
in yohimbine treated rabbits was only from 115 to 135 mg. %. 
This slight rise in the yohimbine treated rabbits could not 
be inhibited, even if the dose of yohimbine was increased to 
25 mg./kg. This study was a confirmation of the previous 
work of Nitzescu (95). 
The influence of the benzodioxane derivatives vms 
tested by Blancher in 1934 (10). Working with rabbits, he 
injected epinephrine in a dose of 0.2 mg./kg. subcutaneously, 
and obtained exactly the same result as Hanson did using half 
of that dose, namely from 115 to 314 mg. %. This rise, how-
ever, was said to occur three hours after the injection 
rather than 1. 5 hours reported by Hanson. It vvas shown that 
diethyl-arnino-methyl-3-benzodioxane (S83F) and piperido-
methyl-3-benzodioxane (933F) injected in doses of 50 mg./kg., 
subcutaneously, blocked this hyperglycemic response. 
Early experiments with Dibenamine, the first in 
the aryl-2-haloalkylamine series, indicated that this agent 
was ineffective in diminishing the hyperglycemic effects 
of epinephrine. Nickerson and Goodman (93) in one of their 
first reports of the pharmacologic activity of this compound, 
reported their experiences in the attempt to block epinephrine-
induced hyperglycemia in rabbits. They injected their fasted 
rabbits subcutaneously with 0.2 mg./kg. of epinephrine, and 
follovTed the blood sugar rise periodically. r hey noted an 
increase of from 100 to 250 mg. % in 180 minutes. That this 
rise is less than that reported by previous workers may be 
accounted for or1 the basis of more sensitive methods for 
blood sugar analysis. If the rabbits were pretreated with 50 
mg./kg. of Dibenamine given subcutaneously, the blood sugar 
rose from 125 to 240 mg. · % in 40 minutes. It was claimed 
that there was no significant difference in the two curves 
except for the earlier peak following Dibenamine. This latter 
effect \'Tas said to be due to a hastened absorption of the 
epinephrine under the influence of the block i ng drug. How-
ever, the authors failed to take into account the f act that 
the hyperglycemic effect st~rted from a higher basal level, 
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~25 mg. % as opposed to 100 mg. %, and hence a reduction in 
the peak response of 25 mg. % could be shown. In addition , 
due to the hastened peak of response with a rather rapid 
return to normal, the area , i.e., the combination of magni-
tude and duration of hyperglycemia, was certainly curtailed 
following treatment with Dibenamine . 
That these small diff erences could be magnified 
into statistical significance was shown by Grant (49) who 
employed the cross-over type of experiment with 12 rabbits, 
and usine the same dosage as Nickerson and Goodman, demon-
strated a statistically significant decrease in t he hyper-
glycemia induced by epinephrine in those animals pretreated 
with Dibenamine. 
Hecht and Anderson (62) have found that Dibenamine 
was ineffective in the blockade of epinephrine-induced 
hyperglycemia in man. 
In 1951 Chen and Clarke (18) attempted to block 
e pinephrine-induced hyperglycemia in rats using another 
of the aryl-2-haloalkylamine series, N-(2-chloroethyl)-
N-ethyl-1-naphthaline methylamine. HCl (SY-14). They were 
unable to i nhibit the effect of epinephrine given sub-
cutaneously in a dose of 0.5 mg./kg. with SY-14 given in 
doses of 6 and 12.5 mg./kg. However, 25 mg./kg. of SY-14 
g iven 1/2 hour before the epinephrine caused a decrease in 
the blood sugar while 50 mg . /kg. blocked it completely. It 
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is noteworthy that if 25 ~g ./kg. of SY-14 we r e given 24 hours 
prior to the injection of epinephrine , there was a complete 
blockade of the hyperglycemia expected . 
Recently, Harvey , Wang, and Nickerson (61) have 
reported on the influence of a series of 15 compounds of this 
2-llaloalkylamine series on e . inephri ne -induced hyperg lycemia . 
Their experiments differed from our own in that t he block ing 
drug a s well as the e pinephrine were injected subcutaneously. 
The blocking drug 1<'~as allowed to act for 4 hours at which 
t ime e pine hrine in a dose of 0 . 1 mg . /kg . was administered. 
All 15 compounds tested manifested some degree of sup9ression 
of hyperg lycemia . It was no~ed that higher doses of block -
ing drug were requir ed to block the hyperglycemi a effect 
tha n to block the blood pressure effect in many cases . How-
ever , it should be borne in wind that the pressor ef fe ct 
of epinephrine is only an algebraic su1TI1 ation of pr essor 
and depressor effects, and only a slight inhibition in the 
pressor effect would cause a change i n the balanc e to a llow 
the depressor effect to manifest itself in what appeared 
to be a partial or complete blockade. Hence in measuring 
pressor responses, one has the depressor effect of epi-
nephrine aiding the action of the blocki ng a gent, while in 
the hyperglycemic response, the bl ocking agent must act 
alone . These wo r k t::J rs did not f ind any corrc:la·cion between 
the ability to sup ress the hyperglycemia and the ability 
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to b lock pressor responses . Thus, these authors felt that 
the conclusions reported for this study (73a) were un-
j ust ified i n view of their data and review of the literature . 
Hovmver , upon the examination of the data reported i n t heir 
. paper, it appeared to this author that there wa s a rough 
a lJproximation of relative dose re qui red for blockade· of 
hyperglycemia and blockade of pressor responses, at least in 
the rabbit . There are several exceptions i n that some com-
pounds affecting the blood pressure response do not ·. ffect 
the hyperglycemia and vice.versa. However , as will be 
shown in the next series of experiments herei n reported , 
the i1 vivo b lockade of epi nephri ne-induced hyperglycemia, 
at least i n rabbits, is by no means limited to the 
adrenergic blocki ng drugs . As regards the revie1-v of the 
literature, Harvey et a l . have gl ea11e d their evidence 
from 1vork done i n several animal specie s . As will be 
po i nted out i n the next series of experiment s , i t i s ne c-
essary to confine one ' s self to a given speci es i n speak-
i ng abo ut this effect , sin ce the response has some degree 
of species spe6ificity . It is still t his author's con-
tention that there appears to be a rough corre l a"cion 
betwe en the po tency of blockini drug i n its effect on 
blood sugar i ncrease and lJressor effect due to epi11ephrine . 
Ellis and Anderson ( 36 ) reported C.:t suppression of· 
epi nephrine-induced hyper glycemi a i n the rat with Dibenamine, 
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S:Y-28 , dihydroergotamine, and Priscoline. Priscoline had 
previou~ly been reported to be ineffective in blocking the 
hypt:rglycernia (60, 66) but this was probably due to an in-
effective dosage level. The imidazoline type of a11:ylc.:unine, 
C-7337 (Regitine), has been reported to suppress e~inephrine­
induced hyperglycemia in maD: (63). 
The natural and dih ydrogenated ergot alkaloids have 
been studied more thoroughly than the other adrener gic block-
ing drugs in this res ponse, probably because of t heir earlier 
a ppearance in the laboratories. As was mentioned earlier 
in this discussion, Miculicich described this property of 
er gotoxin in 1912 ( 88 ) . Bar ger (7) in 193 8 has extensively 
reviewed the older l iteruture on the metabolic a ctions of 
the natural ergot alkaloids , and the reader is referred to 
that reference for the earlier l iterature on t he ~ubject. 
Recent ly, Rothlin (101, 102) has shown that the d i hydrogenated 
derivatives of the ergot alkaloids are increased in potency 
vvhen mea~ured against the hyperglycemic actions of epinephrine. 
Hmvever, this potency vms not increased quite as much as 
against the pressor effects of epinephrine . However , the 
doses required to block the hyperglycemia \"lere much smaller 
than those necessary to inhibit the hypertensive action of 
epinephrine. Dihydroergotamine (112 ), and dihydroergokryptine 
(42) have also b een shown to be a ctive in preventing 
epinephrine- induced hype r glycemia in man. In addition, it 
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has been shown that ergonovine ( 60) , with no k novm adrenerg ic 
b l ocking activity , in large doses blocked hyperglycemia in-
duced by epinephrine. It is this a uthor ' .s belief that this 
is due to some indirect effect since it will be shovin in 
the next section there are other agents -vrithout adrene rgic 
b locking activity "livhich wi ll inhibit t.he hyperglycemia . 
· discussion of the possible mechanisms of action 
of some of these a gents will be found in the l a st section 
of this t hes is. 
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3Ul\'IT-1ARY 
number of adrenergic blocking drugs ware t ested 
i n rabbits for their effec t or1 ep i nephri ne -induced hyper-
g l y cemia . ~ Ti th the exception of dihydr oer gocorni ne , all 
the agents tested be longed to a s eries of 2-haloalkylamines . 
It is 3uggest ed t hat the effectiven e ss of 2-ho. loalkylami ues 
i n diminishing or blocking ep i nephrine-induced hypergl ycemi a 
i n rab its is roughly re l ated to their pot ent y as meo.sured 
by antagonism of other effe cts of ep inephrine . The basis 
for thi s s uggest i on is that the mos t :Jotent drugs bl o ck or 
d i minish t he blood s ugar rise i n a dose of 2 me . /kg . , whi l e 
the l ess potent homo l ogues re quire a dose of 5 mg . /kg . to 
obtain t he same effect . The least potent of these agents 
did not r educe the hyperglycemi a eve n i n a dose of 10 mg . /kg . 
In addit i on , the methyl homologue of one of. these adrenergic 
b locking drugs known to have a markedl y reduced epinephrine 
untugonism d i d no t have any effect on hyperglycemia . Li ke -
wise , when t he halogen is replaced by an hydroxyl group , 
and the resulting agent l oses its epinephrine reversal 
action , i t a lso loses i ts ability to .bl ock e pinephri ne-
i :tlduced hyperglycemiu . A revi ew of the litera ture together 
\vith t he data obtained s eems to indicate t hat it i s a 
general property of the adrenergic blocki ng drugs to ill-
h ibit the hyperglycemic response t o epinephrine in the 
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rabbit. Hov,rever, this effect may have some species speci -
ficity. In addition, some other agents without adrenergic 
blocking activity may el i cit this response. 
THJ:I: EFFE CT OF CERTAI N ANTIHI STM~IINES ON .E:PI NEPHRH E-INDUCED 
HYPEH.GLYCEI,!IA. I ·~ TH 2 RABBI T. ' LSO, THE I NFLUENCE OF SEVERAL 
ANTIHI ST M-li NES AiiJD ADHENERGIC BLOCKI NG DRUGS ON EPI NEPH1li NE -
I NDUCED HYPERGLYCEiv1IA AID LAC TICACIDEIVli A IN THE DO G. 
INTRODUCTION 
Attention has been drawn previousl y to the fa ct 
that several synthetic drugs pos sessing antihistcl.mird c 
propert i es were a l so capable of di mini shing or blocking 
some excitatory effect s of epinephrine (76, 77) . The most 
stri king example was the discovery t hi.1t l-naphthyl methyl-
2-bromoethylami ne HBr (SY-28 ) was a potent adrenergic 
blocki ng drug of the 2-haloal kylamine type, and , i n ad-
di t i on , thi s drug exerted a strong antihist <.:l..in i ni c act ion . 
Thus a single compound pharmacolo gically a ntagonizes the 
effects of epinephrine and histami ne , substances which are 
i n themselves antagonists in many respects . Hevertheless, 
the r;:a j ority of a nt i histamines are fairly s pecific with 
res pect to histamine blockade, although many of them are 
known t o increas e the pressor responses to epinephrine i n 
anesthetized dogs (7?) • .' s i ndicated previously (76, 77), 
the abilit y of antihistamines either to increa s e or de -
crease certa i n effects of epinephri ne s uggests that there 
may be some ::;imilarity in the ultimate site or me chanism 
of action of histamine and epi 1ephrine . The evidence cited 
certainl y suggests that the c.:mt i histarn i ne s vlhich heretofore 
have been r ega rded a s r ather spe cific mi ght i nfluence some 
effects of epinephrine other than those revealed i n previ ous 
studies . 
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Accordingly, s~veral of the available antihistamines 
have been tested for their ability to influence epinephrine-
induced hyperglycemia in rabbits. In addition , the question 
of species specificity as well as the ability of agents 
without blocking activity to influence this response has 
been examined. 
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l•lETHODS 
Rabbits . I11'Iale albino rabbits maintained on a 
diet of rabbit pellets and greens as previously described . 
were fasted for 18 hours prior to an experiment. Following 
the withdrawal of fasting blood samples from the marginal 
ear vein, the a gent to be tested was administered intra-
venously into the other ear in a volume of 1 .0 ml./kg. 
The injection was made slowly at the rate of 4 ml. in 2 to 
3 minutes. Either 15 or 30 minutes later another blood 
sample v.ras withdrawn, and pure ! -epinephrine base in a dose 
of 4.0 gamma/kg . in a volume of 0.1 ml. / kg . was injected 
int ravenously during a period of 30 seconds. The reasons 
for this choice of dosage of epinephrine were mentioried in 
a previous portion of this treatise. Blood samples were 
obtained from the marginal ear vein at 10, 15, 20, and 30 
minutes follm'Ving the epinephrine injection. The experi-
ments vwre arranged so that no rabbit was tested more than 
once \vith a given drug, and at least t~vo agents \'lith a 
saline control were tested on any given day. 
Dogs. oix female mongrel dogs weighing 13-17 
kg . were trained to stand in dog stocks and to submit to 
experimental procedure 1-vithout excitement. These animals 
were fasted for 24 hours before an experi ment. After with-
drawal of a fastin g blood _sample from the vein of a forelimb , 
the agent to be tested wa~ injected intravenously in a 
concentration of 10 mg./ml. over a 3 minut e period . One 
half hour later another blood sample vms vvithdrawn , arid a 
so lution prepared from pure 1-epinophri ne base was infused 
at the rate of 1 garmna/kg ./minute for 15 minutes . Following 
this infusion, samp le s of venous blood were obtained at 0, 
10, 20, 30, 45, 60, 75, and 105 minut.es. In another seri es 
f ollowing inj e ction of 4 gamma/kg. of epinephrine during a 
30 second period, venous blood samples were obtained at 0, 
5, 10, 15, 20 , 40, and 60 minutes. 
All blood samples of both rabbits and dogs i.Yere 
tested for their blood sugar content by the micromethod 
of Folin and Malmros (41). The blood samples were tested 
for their lactic a cid content by the method of Barker and 
Summerson ( 8 ) • 
.31 
TABLE 2. 
Effect of anhhi.~lanl'l: nics on ep?:nephn:ne-inducetl hyperglycemia 
11SEJ) .Hl' AFTF.R l S' AFT E U ~ I f..: ,\ :'\ MI SE I t • O F nos.: I ME AN I. F. VE L ~t E A:< LF.\ ' F. r. J 1 "' 
I CONTR OLf I .V. TREA1'ME~T E PI . 
mgm .j k gm . ± S .li . · S./). ± .'i. O . m~m . r·;J -~-mgm. r·; -~ mgm . r·; 
Saline (1 ·1 rabbit s ) . I ml. 101 ± :~ 1 ~:! ± -1 :~ 1 ± 2 I 100 
I I 
--_ --.-----:;-:---:---~~----,---- ,--=--- ,--=---~---~ ---
N ,:'\-Dune thyl-1'\ - (n · p~Tidyl )- :\ - (n: - 1 fi l ila± 2 llt ± ~ ~ 3 ±·~ I 10 
thionyl) e thylene diaminc· liC'l : ~ 1 !Oil± !l [ 110 ± 13, 3 ± 3 1 10 
(Histadyl) 1 1 I 102 ± : ~ l llfl ± -1 17 ± I 55 
1\ 1 -Pyrid~· l - :\ 1 -5 - l'hlorothcll~ · l-:\' -di - - ~ ~-- ~1 2_±_ 5 ~ 16-±- --;!-3 ±-~--~-
lll('thylethylcnediamine eitrat e I I 102 ± 2 125 ± .) ' 2:3 ± -1 i 74 
(C hlorothen ) 1 _ ___ 1 _ __ ~- _ _ __ _\ \ __ _ 
K 1 -p-:\let hox~· l)('m:y l- ?\' , :\ 1 -d i nwt hy 1-n: - :~ 
pyridylcth~· lenediami ne m:dca t c ( :\ co-
antergan) 
N 1-tl-Dimet hylaminoprop~· lt hi odiphcny l-
amine ·HCI (Phe nergan ) I 3 
I 
I Oo ± ;) 1 11 ± !J 5 ± 2 16 
1- (p-Chlorophen~· l ) -1 - ( 2 - pyrid~· l ) :~ :\' ·i - -;--- ---;-03 - ±-;-[---;-1-1 ±-~ -;-±~ -2fl 
dimethylpropylamine mal eat e (Chl o r·- 1 103 ± 3 1 127 ± -1 24 ± 2 77 
trimeton ) 
------------------ ---- 1-----~----------1-(10-Acrid~· l ) -2-dimeth~ · lamintw thall e : :3 106 ± S 100 ± 8 3 ± 3 1 10 
H C I (Lill~- 01708) · 1 
____ ____ ______ ____ ____ 1 _____ 1 _ ____ 1 _ _ _ _ ' __ _ 
1-Dimeth~· lamillo -2 - (2'-he llzy! - -1 '-e hl o r - 3 lOS ± -1 122 ± 5 1[ 16 ± 2 ' 52 
phenox~·) eth:m e· H C I (Lill y 01780) 
1\ , :'\-Dime~yl-:\' ' - pheny~\ 1 - ( 2 - t~:,~- I~ ~-;---J~07-±-5 11 ~2-I-±-~ ~ ±-2 --58-methyl ) ethylene di a mine· II C I (Diatrin ) i ! J 
/J-Dimethylami:e t h~~~c~zhydr _,~--- ~-;--- !~0-1_±_ 5 1---;-3 1-±-~ll 27 ±-;; - 8;-
ether -HCI (Be n:ulry l) I 
I I 
------------------ ~---- ---- - ----- ~----.---2-Methyl-0-ph e n~· l 2 ,3 ,4 ,fl-t e trahydro -1- 5 I' 10·1 ± 5 ll 131 ± 6 27 ± 2 . 87 
pyridindene tartrat e (The phorin ) [ ! 
1\ , :\'-Dime~~- l-:\' 1 -~;:,ct~ox~· hc llz .~)-- -5--- ---;-06 ±-~~ 28 -±-~1 22~-:;- --71-
1'\ 1 - (2-p:vrimicly I) et h~· l e 11 e d iam i 11 e · 
II C l (:\'eohetramine) 
2[n: - (2-Dimcthylami noe l h o x~ ·) -n: -mc t hyl - 11 5 
benzyl] py ridine sucrin:Itc (Decapryn ) 
N -:\lcthy 1-'X 1 - ( 4-ch lo rohc nz h.Ydry I) 
piperazine·2 H C I (Pcrazil ) 
5 
103 ± 4 . 126 ± ;) 2:3 ± :2 
I I 
I 102 ± 3 ! 127 ± 3 2-1 ± 1 ! 
7-1 
77 
Epine phrine (·1.0 minogm. / kgm. ) was inj ec t ed J.V. ;)O minut e~ a ft er the t e:-; t dru g o r 
tialinc was inject ed. 
*Each drug a nd ea<"h dose we re t es ted in 5 rabbit s from :1 pool o f 15 rabbit ,; . 
t The "p" value o f all a ge nt~ \\·he n compa red with saline IJy gruup means equa l,: < 0 .01. 
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_RESULTS 
A. Hyperglycemia in Rabbits: 
The effects of antihistaminic agents on epi -
nephrine - induced hyperglycemia in rabbits are listed in 
Table 2. It v-ms found that when antihistamines \.vere in-
jected intravenously and slowly, as they were in this 
series, they did not produce any rise in the fasting blood 
sugar level. Thenylpyrami ne (Histadyl) , N-pyridyl- N'-5-
chlorotnenyl-N-dimethylethylenediarnine citrate (Chlorothen), 
Pyranisamine (Neoantergan} , Tripelenamine (Pyribenzamine), 
N' -2 - dirnethylarninopropyl thiodiphenylamine. HCl ( Phenergan), 
Chlorprophenpyridarnine (Chlortrimeton) and 1 - (10-acridyl)-
2-dimethylaminoethane. HCl (Lilly 01798), have been de -
scribed as being among the most potent antihistaminics (20, 
75, 76, 122) . 
These v'lere found to be the most effective in 
diminishing epinephrine- hyperglycemia in rabbits. Such 
activity cannot be due solely to the ethylenediamine 
structure contained in the five compounds listed in Table 
2 , since this structure is absent in the two active com-
pounds, Chlortrimeton and Lilly 01798. Furthermore, 
aminophylline proved ineffective even though the amount 
injected represents at least tl"lice as much ethylenediamine 
as contained in an effective dose of antihistamines of the 
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TABLE 3. 
Effect of vario us agents on epinephrine-induced hyperglycenda in rabbits 
N O. DRUG TESTED1 
Saline-14 rabbits (for '# 1-3) 
Saline-9 rabbits (for '# 4-8) 
1 Aminophylline 
2 Sodium pentobarbital (Nembuta 
3 Procaine HCl 
4 Cocaine HCl 
5 Atropine Sulfate 
6 Pitressin 
7 Pitocin 
8 Ephedrine Sulfate 
DOSE I.V . 
mgm. / kgm . 
1 mi . 
1 ml. 
10 
1) 30 
5 
2 
"3 
0.2 u . 
0.2 u 
3 
MAXIMU~1 RI SE 15 "p" VALUE OF DRUG VS. 
MIN . AFTER EP!. CONTROL2 
mgm. % ± S .D. 
31 ± 2 
31 ± 3 
30 ± 1 >0.05 
30 ± 1 >0.05 
31 ± 2 >0.05 
32 ± 2 >0.05 
31 ± 4 >0.05 
4 ± 3 <0.01 
20 ± 4 <0.01 
6 ± 6 I <0.01 
Epinephrine (4.0 microgm./kgm.) was injected I.V. either 30 min. ( '# 1-3) or 15 min. 
( '# 4-8) after the test drug or saline was injected. 
1 Each drug was tested in 5 rabbits; number 1-3 from a pool of 15 rabbits; number 4-8 
from pool of 12 rabbits. 
· 
2 
'P' value determined by comparison of group means. 
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ethylenediamine type. In .addition, appreciable doses of 
IVlethapheneline (Diatrin), a nd Thonzylamine (Neohetramine) 
which do contain the ethylenediamine structure did not 
markedly inhibit the epinephrine-induced hyperglycmnia. 
The last seven compounds listed in Table 2 are not highly 
potent antagonists of histamine. These compounds only 
slight ly reduc ed the hyperglycemia induced by epinephrine , 
even though the dosage employed was usually 5.0 mg./kg. 
It is suggested, in view of these data, that the ability 
.of the antihistaminic drugs to block epinephrine-hyper-
glycemia in rabbits is related to the potency of t hese 
agents a s measured by the antagonism of the effects of 
histamine on the bronchioles and on the i l eum of guinea 
pigs. 
Since the antihistamines have been regarded as 
fairly specific agents, it was of interest to determine 
whether any agents in addition to adrenergic blocking 
drugs and antihistamines \.'VOUld produce an inhibition of 
epinephrine-hyperglycemia. The agents tested and the 
results are listed in Table 3. Since neither cocaine nor 
procaine altered the blood sugar rise, it is unlikely 
that the effectiveness of the synthetic antihistamines is 
related to their local anesthetic properties. In addition, 
the fact that atropine was ineffective indicates that the 
atropine-like activity of some of these agents is not 
J3 
TABLE 4. 
The effect of antih1:stand.,.w and adrcncro·ic hlockinu tlruys on epinephrine-induced 
hyperglycemia and laclicacidclllia 1'n dvys 
Treatmentn 
BLOOD GLUCOSE 
Mean 
Max. rise 
mgm. % 
±S.D. 
ph 
I 1\Ican area" nf 
hypergly-
cemia 
mgm. min. 
±S.D. 
ph 
I 
I 1--
1 
.Mean 
max. n se 
mgm. % 
I ± s. D. 
BLOOD LA CTI C ACID 
ph 
I :\lean 
'I a rca,. of , 
la c tic- I I acidemia 
I 
mgm. min. I 
± S.D. 
I 
a) Bpincphrine infus io n of mierop;rn ./ kgn1 ./ 111in . fo r 15 min. 
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- ---------------------
Epinephrine in-
fusion Control 
34.7 ± 1.3 1600 ± -1.32 :?i . 2 ± 2. 2 1086 ± 3i6 
Histadyl 1.5 
mgm. / kgm. 
45 . 3 ± 3 . I <0.01 190-t ± 501 0 . 2 <p<0.3 2S .3 ± 2.3 0 .02< p<0 .05 1029 ± 139 >0. 5 
Chlo:-trimeton 
3 mgm. / kgm. 
Chlorothen 
5 mgm. / kgnr. 
N-9-Fluorenyl-n-
ethyl-2 chloro-
ethylamine 
HCI. (Parke, 
Davis SY-21 ) 
2 mgm ./kgm . 
1-Phenyl-2N-
methyl-benzyl-
aminoethyl 
chloride HCI. 
(Lilly 08353 ) 
2 mgm ./ kgm. 
44.0 ± 1.5 <0 . 01 1596 ± 2~2 > 0.5 2R.:? ± I. !i 
28.2±1.1 < 0 .01 
7. 3 ± 2 .3 <0.01 
936 ± 2-t2 10 .0 1< p < 0.02 28. 5 ± 2. 1 10.1 
146 ± 66 I <o. ol l:.l -1. 5 ± z .5 
14 . i ± 1.4 <0.01 359 ± 1-1.0 < 0. 0 I 2\l. 5 ± 2. ti 
Dihydroergocorn- 34 .6 ± 2.6 > 0 . 5 1061 ± 6S5 0 . :3 < p < O.·I 
ined (Sandoz 
I 28.2 .± I . !I ;0. 2 
DH0-180 ) 0 .05 
-0. 1 mgm ./ . 
kgm . 
> 0. 5 1092 ± 158 > 0 .5 
< p < 0. 2 II 92 ± 20-t > 0. 5 
<0 .0 1 lli5 ± 229 0.01<p<0 .02 
< 0 . 01 1094 ± 13 >0. 5 
< p<O.:l 11:22i ± 102 > 0 .5 
b ) l:<~ pinephrinc inj ection of -!.0 nri erognr. / k~~:rn·. O \ ' <' r a :lO-,:<'eond period 
E pinephrine in-
jectio n (Con -
trol ) 
C hlorothen 5 
111gm ./ kgm. 
26 .0±3 . 5 1 604 ± 150 
120.3 ± I . 7 
15.5 ± 2. ·1 <0.0 1 -1. 06 :± ilS 0 . 1 < p < 0.2 21 .:l ± 1. 1 
I 
a Drugs injected 30 min . hdorc Ppine phrinc a dlllini,-tratiun . 
h D etermine d by 'paired data ' analysi s with <"ontmls. 
"Dewrmined by 'Trapezoid Rul<' '. 
I 326 ± 11-1 ! 
> ll.5 :l3 1 ± !15 <0 . 5 
° Combine d results of 2 d op;s with 0.05 mp;m ./ kgm .' and 3 d og,.; witlr 0.1 11 1 ~111 . k~-:n1 . ~i n cc n '" l ' " n :-;(',.; : ll'l' uf ,..: lint' 
11ragnitnrle. Rema inder of drqgs t ested on 6 d op;s <'a<'h. 
responsible for their ac.tivity. It is noteworthy that 
Pitressin, Pitocin and ephedrine were all effective in 
reducing the hyperglycemia. These three agents are all 
known to produce vasoconstriction and other circulatory 
changes. One wonders if these agents could be interfering 
with the activity of epinephrine by a redistribution of 
blood, and a resulting interference with the distribution 
to all parts of the body of any hyperglycemia produced. 
B. Hyperglycemia and Lacticacidemia in Dogs. 
It was important to know whether there were any 
species specificity with regard to the inhibition of 
epinephrine-hyperglycemia. To this end, epinephrine was 
infused into trained dogs at a physiologic rate (15), and 
the blood sugar was measured at intervals in control and 
drug-treated animals. It was also of int erest to know 
whether the lacticacidemia knmvn to occur after ep inephrine 
injection would be affected, thereby reflecting an action 
in muscle as well as liver glycogen. The data are tabulated 
in Table 4. Each dog served as iJGs mvn control. The peaks 
of the hyperglycemia and l acticacidemia have been tabulated 
in addition to the respective areas under the curves from 
onset to completion. It is suggested that the maximum 
rise most clearly demonstrates the effect of epinephrine 
itself, since the duration (refl ected by 'che area) may be 
influenced by a number of other factors such as insulin 
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and adrenocortical hormones. 
The peak response occurred from ten to twenty 
minutes after the end of the epinephrine infusion, and in 
control animals reached a height of about 35 mg.%. Interest-
ingly, Histadyl and Chlortrimeton, which were among the most 
potent of the ant ihistaminics tested in rabbits, did not 
decrease the hyperglycemia in dogs; on the contrary, they 
potentiated the maximum ris e, although they did not alter 
the fasting blood sugar l evel. However, the total area 
of the hyperglycemic curve was not different. from the 
controls. Histadyl produced a significant inc;rease in the 
peak level of lacticacidemia without altering the total 
area of response, while Chlortrimeton produced rto alteration 
in the lactic acid rise follovving epinephrine. It will be 
noted that while the dose of Histadyl used in rabbits to 
produce complete blockade of the hype r glycemic effect of 
epinephrine was 3.0 mg ./kg., the do gs received only 1.5 
mg./kg. Doses higher than this were found to be convulsive 
to dogs, and 1.5 mg./kg. was found to be approximately the 
maximum tolerated dose. 
Chlorothen was well tolerated by the dogs, and 
a dose of 5.0 mg./kg. si gnificantly decreased the hyper-
glycemia both in height and duration without altering the 
lacticacidemia or the fasting blood sugar. 
It will be noted in the experiment on dogs, that 
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the experimental design was altered from that of the rabbit 
experiments in that the epinephrine was infused instead of 
injected. It was important to determine if this change in 
experimental design was responsible for the r esults which 
differed from those obtained with rabbits • . Accordingly, 
epinephrine was injected in~ravenously in a dose of 4~0 
gai!J?1a/kg . over a 30 second period into dogs which had b een 
injected intravenously v'lith 5.0 mg./kg. of Chlorothen 30 
minutes earlier. The results as shown in the bottom of 
Table 4 demonstrate that Chlorbthen reduced t he hyper-
glycemic effects of epinephrine injected in this marmer 
more than 1tlhen epinephrine vms infused. Interestingly, 
t he area of hyperglycemia follovdng the infusion of epi-
nephrine was diminished by Chlorothen, while the ar ea of 
the hyperglycemia follovving the injection of epinephrine 
was unaffected. The findings of Susina and Unna (114), 
using an epinephrine injection of 5.0 gamma/kg. were 
simila r t o those reported herein. They found that diphen-
hydramine (Benadryl) and Chlortrimeton potentiated the 
hype r glycemia while Thephorin diminished it. Their 
measurements of hyperglycemia were exc l usively by areas. 
It is felt that these experiments vvi t h varied 
methods of administration of epinephrine add weight to the 
suggestion that the influence of the antihistamines on the 
response measured is possibly a hemodynwnic one . 
3.6 
In view of the . negative results vvith the ant i-
histarninics in their ability to block the effects of 
epinephrine in inducing hyperglycemia in dogs, a series 
of experiments 1-vere included using the adrenergic blocking 
drugs , N-9 - fluorenyl - N- ethyl-2 - chloroethylamine. HCl ( SY-21) 
and 1-phenyl-2-N-methyl- benzylaminoethylchloride. HCl 
(Lilly 08353) to see if a marked inhibition of epinephrine-
induced hyperglycemia was limited to rabbits. These a gents 
were injected into dogs in a dose of 2 mg./kg., and the 
hyperglycemia following the infusion of epinephrine was 
markedly reduced from the control value both in magnitude 
and duration. Both of these agents caused an increase 
over the control values in the lactic acid rise, but only 
SY-21 produced an increase in the total area of l actica-
cidemia. 
'lhe adrenergic blocking drug, dihydroergocornine 
(DHO ..;.l80) was injected intravenously into dogs, but the 
dose used in rabbits (0.1 mg./kg .) was found to be emetic 
in dogs. It did not produce any change in hyperglycemia 
or lacticacidemia in the 3 dogs in which it was tested ·. 
The dose was reduced to 0.05 mg./kg. and retching vJithout 
vomiting was noted in 2 dogs tested. Again there vvas no 
alteration in t he blood sugar or l actic acid changes pro-
duced by epinephrine infusion. 
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DI SCUSSION 
The reduction of an excitato~y effect of epi-
nephrine by compounds po ssessing antihistamine properties 
has been previously reported . 2-Isopropyl-5-methylphenoxy-
ethyl diethylamine (929F ) (13), 1-naphthylmethyl-ethyl-2-
bromoethylamine ( SY-2 8) (79), a nd N-2 (2-biphenylyloxy)-2' -
chlorotriethylami ne ( SY-8) ( 80) , have been shown t o i nhibit 
the pressor response to injected epinephrine i n dogs . On 
the other hand, sever a l of the available antihistami n es 
helVe been shown to potentiate the effe ct of epinephrine 
in dogs ( 77). FurJchermore , evidence is avai l <:1.ble which 
i nd icc'.tes t hat at least one of the antihistamines, Benadryl, 
is capable of reversing e pinephrine reversal (19 ). The 
me chanism of a ction of the o.ntihistttmines i n their diverse 
effect on the a ction of epinephrine is unknown . It has 
led to the suggesJcion that -che ultimate site or mechanism 
of action of e pinephrine and histamine on certain tis sues 
is simila r (76). It is possible that the antihistaminic 
agents a re effective, therefore, by blocking such a con1r.1on 
site of a ction at the liver . It is more likely, however , 
that the antihist<:'lmines act i n sume non-specific manner , 
such as circul atory changes in which carbohydrate metabolism 
may be only incidentally involved. The fi nding that agents 
such a s Pitocin, Pitressin, and ephedrine, which induce 
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c.irculatory changes, also ;i.nhibited epinephrine-induced 
hyperglycemia in the rabbit, makes this hypothesis likely. 
The failure of some of the potent antihistamines 
to b lock the hyperglycemia in dogs may reveal a s pecies 
di fference, which, as was pointed out in the previous 
section, proved to be an im ortant consideration in evalu-
ating the effects of drugs on epinephrine-induced hyper-
glycemia. With at least two antihistaminic agents, Histadyl 
and Chlortrimeton, there was, i n the dog, a potentiation 
of the hyperglycemia similar to the potentiation of the 
pressor response in this animal. 
To this author's knowledge, there has been only 
one other attempt to study the effects of the antihistamines 
on epinephrine-induced hyperglycemia in the dog. Susina 
and Unna , in 1951 ( 114), working with dogs and using tech-
niques very similar to the ones used in this investigation, 
found a potentiation with Benadryl and Chlortrimeton. 
They found , hmvever, that Thephorin produced a reduction in 
the hyperg~ycemia. The only drug that we used in common 
was Chlortrimeton which we also found potentiated the hyper-
glycemia induced by epinephrine . It will be noted, that 
Chlorothen was the only one of the drugs we tested that 
reduced the hyperglycemic response to infused epinephrine 
significantly both in magnitude and in area. In response 
to injected epinephrine, the dogs pretreated with Chlorothen 
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did not show a significy.ntly lm-rer area of hyper glycemia 
but did not show any evidence of a potentiation . One a lso 
l'ronders if the failure of t he antihistamines t o have any 
effect might not be due to a dosage effect. I t 1-vill be 
noted that t he dose of Hi stadyl could no t be r a ised above 
the 1.5 mg ./kg ., while the Chlorothen was injected in a 
dose of 5 mg./kg . 
Chen and Clarke (17) studied t he effect of Benadryl 
on epinephrine-induced hypergl y cemia in r abbits. l:!:pinephrine 
was injected in a dose of 0.1 to 0.2 mg ./kg. and Benadryl 
in a dose of 20 mg ./kg . Both drugs were injected subcu-
taneously . It was found tha t both agent s were hyperglycemi c 
and that their effects Y~rere additive. The effect of the 
Benadryl could be removed 1ri th pentobarbita l anesthesia. 
Although Benadryl g iven intravenously, as we used it, did 
not cause a s i gnificant hyper glycemia, our results are 
essentia l ly the same as those reported by Chen and Clarke. 
If t he hyper-glycemic a ction of t he Benadryl was removed 
in their experi ments by the use of pentoba rbita l, the 
e pi nephri ne-induced hypergl yc emia was reduced but this 
reduct i on was not stat istically significant . It can be 
seen that i n our experi ment s , t he reduction of only 4 mg . % 
was statistically signifi cant , because it was all i n the 
same direction. However , t his minute reduction does not 
suggest any definit e bio l ogic significance. 
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It is important a gain to point out that ephedrine, 
Pitressin, and Pitocin were all eff ective in reduc ing the 
hyperglycemia. This is in agreement with the previous wo r k 
of Laurin ( 74) and El l is (3 5). These agents all produce 
some circulatory change . Further evidence t hat th e block-
ade of epinephrine-induced hyperglycemia is rwt limited to 
adrenergic blocking drugs is the report that ergonovine ( 61) 
will i nhibit the response. 
Regarding t he effects of the adrenergic blocking 
drugs i n dogs , the SY-21 and Lilly 08353 inhibited the 
hyperglycemia in dogs just as it did in rabbits. The report 
of a potentiation of the hyperglycemia by Sus ina and Unna 
( llL~) using SY-28 in the dog may reflect a spec ies differ-
ence since He found that this compound was effective i n the 
rabbit. Hovvever, in personal communication with Susina, I 
l earned that the SY-28 was injected quite rapidly (about 30 
seconds), and precipitated a rise in blood sugar by i t s m~m 
action . Our technique v-.ras to inject the drug over a 3 minute 
period.. One wonders if this difference in techni que was not 
res ponsible for their failure to elicit a b l ockade of the 
secondary hyperglycemia due to epinephrine. A slight initial 
hyperglycemia might sum with a reduced epinephrine-induced 
hyperglycemia resulting in an apparent potentiation. However, 
the work of Harvey et . al. ( 61) wh ich was dis cussed in the 
l ast s ection s eems to indicate that the effici ency of the 
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blocking drugs may be sp ecies specific . The absence of 
any effect with DH0-180 may be due to a dosage ef f ect. 
It was used in a dose of 0.05 mg . / kg . as opposed to a 
dose of 0.1 mg . /kg . used in rabbits but which was toxic 
i n dogs. .Susina and Unna ( 114) were unable to inhibit 
epinephrine-induced hyperglycemia in dogs '\'lith dihydro-
ergotamine injected in doses of O.l to 0.25 mg./kg . How-
ever, when they increased the dose to 0.5 mg ./kg ., they 
d id demonstrate a blocking of the blood sugar rise due to 
epinephrine. They reported that t he se doses also caused 
retching. 
The failure to reduce the lacticacidernia following 
epinephrine in dogs may be a circulatory effect . It could, 
of course, a lso be clue to a failure to block at the mus cle. 
I n a ddition we should consider the possibility that it re -
flects an increased ut ilization of blood sugar or a de -
creased remova l of lactic acid from the blood strerun by the 
liver. These various possibilities will be considered in 
the discussion of the next section. 
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SUMMARY 
Although a majority of adrenergic blocking drugs 
have been shown to diminish ep ine phrine-induced hyper-
glycemia in rabbits, it has been observed that potent anti-
histamines and several pressor agents are likewise effective . 
A number of the available synthetic antihistamines have been 
tested for their effects on epinephrine-induced hyper-
glycemia and lacticacidernia in dogs. It was found t hat -chose 
compounds which have been known to be the most potent in 
antagonizing the effects of histamine on the bronchioles and 
intestine of guinea pigs, are also the most effective in 
reducing the epinephrine-hyperglycemia in rabbits. The 
effectiveness of the antihi staminic agents is not related 
to their ethylenediamine structure, their atropine-like, or 
their local anesthetic activity. Pressor agents such as 
Pitocin, Pit ressin, and ephedrine diminished the induced 
hyperglycemia in rabbits. It is suggested that all these 
agents work by some non-specific effect, influencing the 
carbohydrate response to epinephrine only incidentally. The 
evidence suggests that antihistamines inhibit epinephrine-
induced hyperglycemia more readily i n the rabbit than in the 
dog, which may reveal an important species difference. None 
of the ant i histamines or adrenergic blocking drugs tested in 
the do g decreased epi nephrine-induced lacticacidemia. 
43 
THE INFLU.t.NCE OF ADRENERGIC BLOCKING DRUGS AND NEO NTERGAN 
ON EPINEPHRINE-INDUCED EFFECTS ON GLYCOGEN, GLUC03E UPTAKE, 
AND OXYGEN CONSU.MPI'ION OF THE ISOLATED HEJIHDIPHRAGI"l 
AND LIVER SLICE OF THE RA'r 
It is felt that _before going into the experimental 
results of the next and last section of this series of 
studies, it would be advantageous briefly to review the 
highlights of the literature on the mechanism of the 
epinephrine-induced hyperglycemia. That epinephrine causes 
a liver glycogenolysis is incontrovertable. The question 
is what part in this carbohydrate plethora is played by a 
decreased utilization and/or uptake of glucose from the 
blood stream. 
This has been the source of a great deal of con-
fusion in the literature. The main difficulty is that in 
the intact animal it is difficult to measure separately 
the glucose uptake and the glucose utilization, and the 
terms have become linked, when actually they should not 
be so. 
Cori ( 26) has marshalled evidence from vvhich he 
concludes that epinephrine-induced hyperglycemia is in 
part due to a decreased utilization of blood sugar by 
muscle tissue. This conclusion is based on three main 
theses. 
1. The amount of glucose which he had supplied 
to normal rats in order to produce a hyperglycemia of similar 
magnitude and duration as that caused by certain doses of 
epinephrine, was such that it could not possibly be derived 
from liver glycogenolysis. 
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2 . Si multaneou.s determinations of A-V blood 
sug<=Lr l evels in man and rabbit s have shown that for the 
same degree of hypergl ycemia, the . -V blood sugar differ -
ence 1,vas greater when the hyperglycemia 1-vas caus ed by 
s ugar administration t han when it was due to epinephrine 
injection. This , however, was a measu rement of gluco s e 
uptake, as has been defined in an earlier part of this 
d i s s ertat ion . 
3. Colwell and Bright (25) have reported that 
when ep i nephri ne and glucose were continuously i n j e cted 
i nto amytali zed cats, t h e non-protein R. Q. (instead of 
rising progr es sivel y a s under identical co nditions with-
out epinephrine ) dropped to t he fat level within 3-5 hours, 
and r0mai ned there us long us the epi nephri ne admi nistration 
pe r s isted . These ani mals excret ed an i ncreasi ngly grea ter 
pr oportion of sugar administered . The autho rs concluded 
t hat epi nephrine was capab l e of suppressing glucose utili-
zation even in t he presence of an i ncr eased supp l y . 
This theory of de creased utilization of blood 
glucose has been a very provocative one , a nd many vmrkers 
have at tempted experi ment s to verify or deny i Jcs validity 
(cf . Gri f f ith (50) for extended r eferences) . Mo st of the 
work ho.s been performed on intact animals , and the results 
obt a i ned have been most confusing , for t he utilization of 
blood glucose has been shown to be i ncreased, decreased , 
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or unaltered by epinephrine. Each investigator is quite 
certain that his own view is correct. Leading among those 
investigators supporting the view that the utilization is 
decreased is Cori, and among those advocating increased 
utilization are Soskin and Griffith. Soskin (lll) has been 
of the opinion that the method employed by Cori and others 
of comparing the hyperglycemia of injected glucose with 
that induced by epinephrine is unwarranted. They cite the 
experiments of Mann and IVIagat .i:l ( 84) who claimed that the 
liver itself must use large quantities of injected glucose 
since the hepatectomized rats required only about l/10 the 
amount of glucose used by Cori to simulate the blood sugar 
rise produced by epinephrine. It becomes a problem of 
whether there is any essential difference bet\•reen the 
metabolism of exogenous or endogenous circulating sugar. 
Soskin and his co-workers (lll ) claimed that one 
could not consider measurements of arterio-venous differences 
a valid estimate of blood sugar utilization unless, concomi-
tant measures of changes of blood flow W8re made. Here 
again we have an example of the source for confusion i n 
,..,-hich glu cose uptake is called glucose utilization. They 
reasoned that an increase in blood flow could account for 
a decrease in utilizat ion, and proceeded to measure the 
blood glucose A-V differences taking into account blood 
f low and hydration. They removed samples f rom the carotid 
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artery , femoral, portal , and hepatic veins. Epinephrine 
\vas inj ect ed intravenously at t he rate of 0.12 mg ./kg ./hour 
into amytalized dogs and their results indicated that there 
was no evidence that epinephrine decreases the utilizat ion 
of blood sugar by the muscles of t h e hind l imb. 
Cori, Fisher, and Cori (32 ) upon revising their 
experiments criticized Soskin's group in two main aspects . 
They claimed tha t Soski n 's solution of epinephrine was not 
prote cted by antioxidants, and injected over such a l ong 
period of time that the so l utions may have spoiled. 'l,hey 
f urther noted the:'lt the blood flow gradually declined to 
extremely low levels in each experiment, indicating a poor 
physiological condition of the dogs. The method of record-
ing the blood flow (one which remov ed the blood from the 
dog 's body and then reinjected it) was one which might have 
led to a gradual det erioration of the condition of the dogs 
and the circulation of the blood. 
Three years l a ter, the Soskin group (109) repeated 
their. studies using a di fferent me t hod for recording the 
blood flow. Again, they coul d not demonstrate an increase 
in glucose uptake due to epinephrine when they considered 
the che:mges in blood flow in their cal cula11 i ons . The in-
creases in blood flow were substantial, and t ended to in-
crease the glu cose u pt ake rather than decrease ii. 
Cori and his co:-vwrker~ (3 2) then decided to 
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investigate the matter a gain using measurements of blood 
flow. In amytalized dogs they noted that only 0.015 mg. 
of e pinephrine/kg./hour caused a hyperglycemia ·of about 
the same magnitude as that obtained by Soskin with eight 
times that dose. In addition, they noted that this rate 
of injection not only produced a hyperglycemia without 
any change in blood flow through the leg, but also pro-
duced a steady hyperglycemia instead of the erratic 
changes noted by Soskin. Instead of measuring the A-V 
differences as compared to injected glucose, they measured 
the differences as compared to insulin, and noted that 
while epinephrine caused an increase of only 1-2 mg. %, 
insulin caused an increase of 10-25 mg. %. This is a rather 
peculiar comparison since the amount of increase of utili-
zation caused by insulin would probably vary with the 
dosage. The experiments, hmvever, are significant in that 
they afford evidence that hyperglycemia could be i nduced 
without alteration in blood flow. 
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It was Corj_ 's contention that the measurements of 
the blood flow are not essential in evaluation of A-V differ-
ences. He showed that the error of :f.. l mg. c;; for the determi-
nations of blood sugar was so great that it is us eless to 
calculate with the a ppropriate changes in flow. For example, 
a set of values of 143 and 138 for the arterial and venous 
b l oad glucose levels, respectively, would give a difference 
of 5mg. %. Assuming an error of l 1 mg . %)then a difference 
of 144-137 = 7 or 142-139 - 3 mg . % mi ght also be found. 
With a blood flow of 4 cc/ minute through the leg, the sugar 
retention in the 3 cases would be 120, 168 , and 72 mg./ hour 
res pectively. Hence with such a large error, the utilization 
could be shown to change even if it was exactly the same 
for three consecutive measurements. The best that can be 
hoped for by measurements of A-V differences may be a 
qualitative index. 
There have since ~een many investigators who have 
duplicated the experiments and results of both Soskin and 
Cori. There are two outstanding experiments which should 
be cited for their significance. Soga (106) showed that 
continuous administration of glucose inhibited the fall i n 
blood glucose of hepatectomized dogs. If epinephrine was 
infused along with the glucose into such dogs, there was an 
increase in blood sugar and a decrea se in muscle glycogen. 
I n the hepatectomized dog, such a hyperglycemia could only 
be due to a decrease in glucose uptake and/or a decreased 
utilization. The finding that the muscle glycogen decreased 
does not aid i n the interpretation, since it may be due to 
either or both of these possibilities. However, since e pi-
nephrine did not prevent the fall in blood sugar in an 
hepatectomized dog which was not treated with glucose, there 
was the indication that epinephrine could only act in the 
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face of a g iven critical level of blood sugar . 
Another experiment of significance 1-vas performed 
in unanesthetized humans by Somogyi ( 10 7). He employed a 
dose of epinephri ne of 0.2 mg . subcutaneously, a dose so 
small that it did not alter the pulse rate or blood pressure, 
and produced a rise in blood sugar of only 13 mg . %, an 
hyperglycemia equivalent to ·che ingestion of 5.0 gms. of 
gl ucose . A subject vms f irst fed 50.0 gms. of glucose 
without any epinephrine administered , and the A-V differ-
ences - in blood glucose following the c:.li rnentary hyperglycemia 
\vere r e corded. A fevv days later the subject went through a 
second test which differed from the first only in that the 
subject received 0.2 mg . of epinephrine, subcutaneously, ten 
minutes befor e the ingestion of t he 50. 0 gms . of glucose . 
It was noted t hat t h e hyperglycemia resulting from the com-
bined epinephrine and glucose was greater than tha t due to 
glucose alone . At the same t i me the A-V difference was less 
in the hyperg lycemi a due to epinephrine and glucose than in 
the hyperglycemi a due to glucose alone . This l atter f inding 
indica ted that the greater hyperglycemia when epinephrine 
was g iven in addition to glucose was due to a decreas ed 
glucose uptake and/or utj_lization by the tissues. 
These data revealed another important bit of in-
format ion. It wa;:; no·c ed that vii th epinephrine plus glucose, 
the blood sugar rose to higher peaks and ·chen dro pped much 
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mo re steeply than the glu~ose co ntrols. Thi s vias <m in-
dication of a marked. increase in insulin se cretion, and 
the ever- present dynamic balance between insulin and epi-
nephrine. The resulting hyperglycemi a and glucose utili-
zation is nothing more than the result of a n antagoni st ic 
a ction of the s e t wo substances. \ s indicLt ed several times 
above, it may be that the results of some workers shovving an 
increase in utilization v-1as due to c.m increa se in i nsulin 
secretion. On the other hand, the results of bOrne i n -
ves~igators indicat ing a decrease in utilization could be 
caused by c.:t.n additional output of adrenocortica l hormone 
(69 ), for it should be clear that epinephri ne will act in 
the intact animal upon the existing endocri ne state of that 
i nd ividua l. Indeed, some of So s kin's (109) graphs indicate 
that there was some degree of hypoglycemia at the start of 
their experiments, suggesting that there may have been a 
good deal of circulating insulin. In addition , i n Soskin's 
experiments, the experimental design \K1S such that glucos e 
was infused, and after the return to normal the epinephri ne 
was injected. The hyperglycemia induced by glucose infusion 
mi ght have caused large amounts of insulin to be released, 
which may not have been entirely destroyed by the time 
e pi nephrine was administered, and the primary a ction of in-
sulin could counteract the effects of epinephr ine, as shown 
in the isolated muscle st~dy of Riesser (100). 
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In as much as the results are so variable regard-
ing the effects of epine phrine on glucose utilization, it 
appears to be almost impossible to predict the effect of 
a given injection. However, it is of interest t o evaluate 
the various factors contributing to the end result. One 
of the ways of evaluating these factors is to pla ce the 
tissue in isolation, and thus remove the various hormonal 
influences. 
There have been a good many studies on isolated 
tissue, but comparatively few studies on the isolated 
skeletal muscles alone, which in the opinion of many, con-
tributes the greatest area of the utilization of carbo-
hydrate. 
Most of these experiments can be criticized in 
that the tissues have been severely i11jured in removing them, 
mincing and homogenizing . In order to minimize the trauma 
of preparat1on, the rat diaphragm has been suggested by 
Gemmi l l (44) for these studies. Two I~raeli workers, 
Tuerkescher and i'"ertheimer ( 117) presented an interesting 
study. They used rats that were first anesthetized with 
Nembutal. The animals were bled, the diaphragm was removed 
and placed in a Warburg apparatus. As a measure of glycogen 
synthesis, the difference in glycogen content between one 
test sample incubated for 6 minutes and the other for 3 hours 
vvere used. Difference in glycogen following the addition of 
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e pinephrine was measured by the difference in the glyco gen 
content of 2 samples after 3 hours of incubation; one 
s ample being i ncubated in the usual manner, and the other 
1--vi t h epinephrine added. Glucose vms present in the medium 
in a concentration of 100 mg. %, and the experiment wds con-
ducted in an atmosphere of pure nitrogen. Glycogenolysis 
was measured by the decrease in glycogen in 3 hours of 
incubation in a glucose free medium. The addition of epi-
nephrine HCl at a concentration of 0.33 gamma/ ml. regularly 
decreased glyco gen synthesis by about 44~b ; at 0. 0033 gamma/ 
ml ., the effect disappeared, and at 0.033 garllma/ ml . the 
effect 1-vas irregular. The decreased glycogen :3yrwthsis in 
the diaphragms with epinephrine added could be observed 
after one hour . The eff ect was blocked by ergotamine 
tartra"ce (8 .3-10 gamma/ ml. ) which itself reduced the rate 
of muscle glycogenesis . Therefore, the effect of ergotamine 
must have been due to a blockade of the action of epinephrine. 
It was of interest to note that at a concentration of epi-
nephrine of 0.33 garmna/ml. there was an increase in glyco-
genolysis of 477; . This is to be compared with the decreased 
glycogen synthes is with epinephrine of 44%. This finding 
indicates tha t the apparent decrease in glycogen synthesis 
was probably a reflection of an increased glycogenolysis due 
to epinephrine. 
Cohen (22) reported a series of experiments on the 
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effect of epinephrine on glucos e utilization in the isolated 
rat diaphragm. He ~ms unable to demonstrate any effect of 
epinephrine added in doses of 50 - 100 gwm-:1a in vitro. There-
fore, he injected epinephrine in a dose of 1 mg ./kg., sub-
cutaneously into rats 40 to 70 minutes before removing their 
diaphragms. The tissues were incubated in an atmosphere of 
nitrogen containing 5ib carbon dioxide to equalize the bi-
carbonate solution. The medium contained 0.2% glucose, and 
he measured the rate of anaerobic glycolysis. Si nce the 
lactic acid produced as a result of anaerobic glycolysis 
would release carbon dioxide from the bicarbonate i n the 
me dium, a measure of the carbon dioxide released \'Vas a 
measure of the anaerobic glycolysis occurring within the 
muscle. 
The glucose entering the tissue l\rould presumably 
be phosphoryl ated , and then either conver'Ged to glycogen, 
broken dm.'VIl to lactic acid, or stored as hexosemonophosphate. 
Although Cohen found an accwnulation of phosphate in both 
the control and epinephrine-treated diaphragms after in-
cubation, he was unable to demonstrate any difference in the 
amount of a ccumulation of phosphate s bet\veen thes e tv.ro groups. 
While the glycogen content of the untreated diaphragms de-
creased af'Ger incubation with glucose, the glyco gen content 
of the epinephrine-treated diaphragms did not change after 
incubation with glucose. Oddly, the glycogen value of 
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epinephrine-treated diaphragms did not change even when they 
were incubated in the absence of glucose, although lactic 
acid was still produced!! One wonders what could have been 
the precursor for lacti c acid. The lactic acid (measured 
by the carbon dioxide released and checked by chemical 
determination) produced by the epinephrine-treated diaphragms 
\"las significantly less than that produced by. t ·he control 
diaphragms. From this, the author concluded that there was 
a decreased glycolysis due to epinephrine. He claimed, since 
there was no change in the glycogen content of the epinephrine-
treated diaphragm before and afte r incubation, that the de-
creased rate of glycolysis was akin to a decreased rate of 
utilization of the glucose entering the tissue. Since there 
was no difference in the phosphate i ntermediates content 
between the corrcrol and epinephrine-treated tissue, the 
decreased glycolys is vras also ar1 indication of a decreased 
rate of glucose uptake. 
However , Cohen did not measure the rate of dis-
appearance of glucose from the medium. Since the glycogen 
value of the epinephrine-treated tissue did not change from 
the initial value following incubation, whi le it decreased in 
the control diaphragms, some of the glucose tcllien up from the 
medium must have been converted to glycogen. Therefore, it 
is possible that the rate of glucose uptake may not have de -
creased even though the rate of glycolysis decreased. 
5.6 
An interpretation of these experiments is difficult 
to make. The observation thc.ol..t epinephrine added i n vitro i n 
doses as high as 50 - 500 gamna produced no effect on any 
of the facets of glycolysis measured is mos t surprising . It 
a ppears that when epinephrine vms injected into a rat before 
the diaphragm ~o-vas removed and incubated, that an inhibition 
in anaerobic glycolysis did occur. At least in these ex-
peri ments, it does not seem that the inhibition was due to 
an ac cwnulation of intermediates, sine e they "'lt'lere not 
appreciably different from the controls. Cohen did der.lOn-
strate that t here. vvas no reduction of glycolysis in 
epinephrine- treated diaphragms if they were incubated in 
hexose diphosphate, which indicates that there was some 
i nterfe rence before that part icular step in the glycolysis 
chain. 
The finding that epinephrine added to diaphragms 
in vitro had no effect, led Cohen to another series of 
experiments ( 23) in an attempt to find the possible me cha-
nism of act ion. He reasoned that either the epinephrine 
vvas transforrnt:Jd i nto a more active compound somewhere in 
the body, or else in view of the existing knowledge of 
hormonal balance, the epinephrine st imulated the hypophysis 
or adrenal cortex to activity, and this was the actual 
agent i nvolved. He repeated hi::; experiments using 
hypophysectomized and adrenalectomized rats, and his results 
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are quite interesting . Iu vi::t s observed that e . inephrine 
injected into an hypophy~ectomi z ed rat did not produce 
inhibition of glucose utilization, indicat ing that the 
indirect action of epinephrine \vas probably mediated 
through the hypophysis. rv1oreover' this indirect action 
of e pinephrine i s independent of the adrenal cortex, s ince 
epi nt)phri ne injected into adrenalectomized r a ts still ex-
hibited the i nhibition. 
A Dutch investiga tor, Riesser (100), reported a 
study of the effect of epinephrine on the iso lated rat 
diaphragm. This study was not conducted in the Vlarburg, 
but in a flask kept at constant temperature. In addition , 
the preparation 1>Vas a rib-diaphragm preparation, rather 
t han a diaphragm alone. This type of preparation i nvolved 
less cutting 'of the 11uscle fibers of the diaphragm, and 
presumably the presence of bone would not appreciably in-
f'luence the glycogen content of the muscle during incubation. 
After incubating the tissue in oxygenated solution of 
phosphate -buffered Hinger's solution containing 0 . 5~~ glucose 
for 3 hours i n the p esence of such mass ive dos es of epi-
nephrine as 50-100 gamma , the glyco gen level '>vas seen to 
fa l l. However, since no measurement of glucose or l a ctic 
a cid ltvere made , there is no way of telling whe"cher this 
a ction was due to an increased glycogenolysis or an in-
h ibition of glucose uptake . The author was of the op i nion 
that both explanations ap: lied . He showed that the muscle 
glycogen decreased even in the presence of i nsulin , and 
took this to mean that there v-ms an antagonism of insulin 
by epi nephri ne , s ince the action of insulin is generally 
a c cepted to be t o increase gl ycogenes is and to prevent 
glycoge no lysis . 
As can be seen from the foregoi ng , the existing 
experiments with the intact ani mal dealing with the effect 
of epinephri ne on glucose uptake and utilizati on present s 
a rather confusing picture . If the reader will re ca l l the 
water analogy given i n the Introduction, the leve l of water 
(blood sugar) in a si nk (blood stream ) could rise not only 
by increasi ng the rate of wat~r i nflow from the faucet 
( liver gl ycogenolysis) but also by decreasi ng the rate of 
outflow from the sewer-drain (glucos e upt ake and utilization 
by the t issues) . I t has a l ready been po i nted out that t he 
rate of glucose uptake and glucose utilizati on, i f defined 
individually , can vary in.depe nd ently of each uther because 
of the ability of muscle and liver tissue t o store hexosemono-
phosphate . In t he intact animal it is qui te difficult to 
measure both the glucose upt ake and the gl u cose utiliz~tion 
independently, and the best one can hope fo r it> to IJeasure 
the rate of glucose uptake from the blood stream by the 
tissues . The techni que for thi s measurement is t he deter-
mir at i on of the - V difference in bl ood sugar . HovJever, when 
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this is done, the glucose _ uptake can be shov·m to either in-
crease or decrease fo llowing epinephri ne admini strat i on . 
Some attempt has been mc.}de to correct for the changes in 
blood floV~r due to epinephrine on the theory that glucose 
spends less time at the cell membrane, and, therefore, less 
is absorbed , and the glucose uptake appears to decrease. 
On the other hand, one may consider that an increase in 
blood flow presents more glucose to the cell membrane per 
minute. In such a case, an increase in uptake by dint of 
mass action effects rather than any enzymatic facilitation 
by epinephrine may be the responsible factor. However, 
despite correction for blood flow different laboratories 
have shown the glucose U) take to increase or decrease 
following epinephrine injection. 
It has been pointed out by Cori's group (32) that 
the error in the determination of the A-V differences is 
such, that it is difficult to rely upon such measurements 
as quantitative indicators of glucose uptake. 
It should be remembered that in the int,act animal 
the i nfluences of other hormones might play a role i n the 
final observed effect . Thus epinephrine could increase the 
rate of glucose uptake by the tissues and a t the same time 
stimulate the secretion of adrenocortical hormones by way 
of the anterior pituitary. The adrenocortical hormones are 
k nmvn to decrease glucose uptake. Thus, in Cori' s experiments 
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in which small doses of ep inephrine were used, the a ction 
of the adrenocortical hormones could overshadow the action 
of e pinephrine. On the other hand, in Soskin's experiments, 
the doses of epinephrine used were relatively l arge , in 
\vhich case the action of e pinephrine could still be domi -
na nt despite the presence of adrenocortical hormone. 
Studies on the isolated muscle have done little 
to clarify the situation, pri marily because th~ rate of 
glucos e disappearance from the mediwn was not measured. 
lViost of the isolated studies which do not use the diaphragm 
are generally diffi cult to interpret because of the possible 
injury done to the tissues by mincing and homogenization. 
Iv'lost of the studi es with the rat diaphragm give some in-
dication that the glucose utilization is decreased, but the 
available informat ion is so scant that no definite conclusions 
can be reached. 
A po rtion of the experimental data in this section 
is based on the effects of epinephrine on the oxygen con-
sumpt ion of isolated liver and muscle. It is believed 
appropriate, at this point, to discuss some of the outstand-
i ng papers on the cdlorigenic effects of' epinephrine in the 
i ntact animal. This discussion is by no means meant to be 
exhaustive, but is only meant to po int out the h i ghli ghts , 
and to place some type of order in a subject which is in a 
rather chaotic state . 'Ehe reaaer i s referred to the recent 
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review article by Griffit/h (50) for an excellent detailed 
bibliography. 
Administration of epinephrine in physiological 
dosage to the intact animal leads to an increased respira-
tory metabolism--an increased 02 utilization which is inter-
preted to be an increase in caloric production by the body. 
Thus one describes a "calorigenic!! action to epinephrine. 
Such a calorigenic activity is an in~ricate part of the 
nemer gency theory" which Cannon has introduced to explain 
the diverse activities of the adrenal medullary hormone. 
Attempts to demons'Grate a calorigenic action on 
isolated tissues have led to results so contradictory as 
to be completely inconclusive. In an attempt to determine 
whether the hormone is a s pecific or general stimulant to 
cellular metabolism, nearly all organs and tissues of the 
mammalian body, and some others have been tested in vivo or 
in vitro . These include the adrenal gland itself, blood 
c e lls, brain, heart, kidney , liver, nerve trunk, placenta, 
pituitary, sarcomas , s ke letal muscles, smooth muscle, skin, 
thyroid, turners (50). Also, mere separation into a pre-
dominantly visceral or peripheral locus has been attempted 
by use of hepatectomiz ed or eviscerate preparations or of 
single limbs ( 14, 53) • Griffith, in surveying the situation 
in 1949 (51), says, 
H ••• of the variable reports, some 52 rnc:q be inter-
preted as indicating general stimulation, 24 
6.2 
describi ng i nhibit i on, 29 i ndicating no effect or 
at least none in the absence of the liver, and ll 
suggesting that the effect depends upon the concen-
tration of epinephrine , or of the availability of 
oxygen or presence or absence of functioning 
syrapa theti c nerves .. 11 
It will be helpful , I believe, to mention briefly 
here again the Cori cycle, which was discussed in the Intra-
duction . Epinephrine acts on muscle glycogen to cause 
glycogenolysis wh ich will produce a subsequent formation 
of pyruvic a cid and l a ctic acid . In the presence of 02, 
the Pasteur effect will occur, and pyruvic acid vvill enter 
the Krebs' oxidative cycle, and vfill form C02 aud H20, 
utilizing 02 in the process . That this process may be 
involved in the calorigenic activity of epinephrine is 
indicated by the fact that very often in isola ted tis s ue 
preparations where adequate 02 i s present, the R. Q. 
(C02/02) is equal to 1. In the face of excess glycogenolysis 
and insuffic ient oxygen, l a cti c a cid wi ll be formed .. In 
the mammal 3/4 of this lactic a cid is carri ed to the liver , 
and converted to l i ver glycogen , -v-..rhi l e l/4 remains behind 
to be oxidized to give energy for the reformation of 
creatine phosphate . The energy required for the conversion 
of lactic a cid to l i ver glycogen, probably comes from f a t 
combustion, again an oxidative process . Thus in long term 
experiments i\rith intact animals , the H. Q. was that of fat 
coi~ustion (25) . The liver gl ycogen is split by epinephri ne 
to form blood glucose vvhich is transported to the muscle to 
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be converted into muscle. glycogen and the process starts 
all over again. The cycle may be represented diagramati.-
cally as follows. 
Blood glucose ) 
1 
Liver 
Glycogen A f rom 
fat oxidation in 
liver 
Muscle Glycogen 
1 
Pyruvic acid~ C02 ,L H20 
Lactic acid ~ 6 
Two factors appear to be r ather well settled as 
will be shown below . First, that hyperglycemia produced 
by epinephrine is not suf ficient t o cause an i ncrease in 
caloric output. wecond, that muscular activity contributes 
only a very small fraction of the metabolic response, and 
then only unde r conditions of acute severe stress. 
I should like to begin the discussion by giving 
a very brief resume of the early work in the f ield. The 
studies on the effect of epinephrine on the metabolism as 
evidenced by alteration in the quantity and character of 
the gas eous or respiratory exchange were initiated by 
Barcroft and Dixon in 1906 (6). By means of perfusion of 
the coronary systelll of an excised heart, and determination 
of the co2 and 02 tension of blood, they demonstrated that 
a fter addition of epinephrine, the oxygen consumption was 
i ncreased 3 or 4 times. Bernstein and Falta found in 191 2 
( 9 ) that in man, 0.1 mg. ·- of epinephrine injected subcutaneously 
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r _esu l t ed i n a rapid increa~e in oxygen consumption which 
reached its he i ght 1 hour after the i n j e ction . Anderes 
and Cloetta , in 1916 (5), demonstrated an increase in the 
volume of the blood through the luugs which accornpe.ni ed 
the increase i n oxygen absorption. Sandiford in 1919 
( 103) vms the first to demonstratt3 that epinephrine did 
not exert it s effect through the t hyroid gland. This was 
confirmed by lvlarine and Lenhart in 1920 ( 85) i n thyroid-
ectomized rabbits. Jumping for a moment to 1946, De 
Vi sscher ( 119) showed t hat thyroidectomy in the rabbit 
did not completely abolish the action of ep i nephri ne on 
gaseous exchange until 20 days after operation. Subse-
quent injection of thyroid hormone returned the re s ponse 
to normal , providinglarge doses of thyroxin were used. 
Small doses did not return the respons e to normal. He 
conc l uded that the action of the thyroid hormone was to 
sensitize the t issues to epinephrine calorigenic activity. 
The first attempt to show that t he calorigenic 
a ction of ep inephrine was something over and above the 
mere i ncrease in blood glucose was by Boothby and Sandi ford 
i n 1922 ( 12) • They had 44 experiments on human subj ects 
in which the i ncrease in heat production, R. Q. and blood 
sugar from the injection of 100 gm. of glucose was compared 
with the results obtained in 22 experiments f ollowing 
subcutaneous injection of' 0 .5 mg. of epinephrine. It was 
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noted that the i n jection af glucose cau~ed a 9% increase in 
heat production for an increase of blood sugar of l05 fo , 
while from e pinephrine there \vas a 2~~ increase in heat 
production with only a 3 75·; increase in blood sugar, and 
less of an increase in R. Q. 
It was not until 1923 that Boothby and Sandiford 
introduced the term "calorigenic actiontt (12). It was 
this paper which was classical for its well controlled 
observations in which the effect of muscular activity was 
ruled out , a variable which complicated most of the 
preceeding reports. They used unanesthetized do gs which 
were trained to lie perfectly still throughout the ex-
periment. They watched the dogs carefully maki ng note of 
any movement a t all. To be sure of a permanent r ecord 
of this there were 2 pneumo graphs around the dog. The 
first passed over the upper part of the chest just behind 
the forelegs , in such a manner that the slightest move-
ments of the forelegs or head vvere indicated on the 
Kymograph tracing. The second passed over the lower part 
of the trunk just in front of the hind legs so that move-
ments of the hind legs as well as those of the tail were 
recorded. It was found that the involuntary twitching 
of "che leg whi ch occasionally occurred had no effect on 
the metabolic rate. lVIany of the observations may have 
been on sleeping dogs, since they had no vvay of t e lling 
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whether the dog was awake. or asleep. 
Epinephrine was infused intravenously, at the 
rate of 0.6 to 2 .5 gamma/kg./rninute for 6 to 13 minutes. 
The rise in pulse rate, and respiratory rate, and respira-
tory volume paralleled the increase in metabolic rate. 
'!'hey postulated at this time that ~che effect of epinephrine 
was general on all types of cells, and since they had sho\.'Vll 
that the effect could not be attributed entirely to an in-
crease in blood sugar they suggested that the metabolites 
of the utilized blood sugar may be involved. 
There are t"\VO other outstanding papers which 
should be mentioned, showing that .the calorigenic act ion 
of epinephrine is something besides the effect of a hyper-
glycemia. Corkill, Dale and l'vlarks showed in 1930 (33) 
that epinephrine injected into eviscerat;e cats caused an 
increased oxygen consumption. This contradicted the 
results of Soskin (108) of 3 years earlier who obtained 
the opposite result. The difference may possibly be ex-
plained by the work of Cori (27, 28) on frogs, which 
shovv-ed that as the hepatectomized animals began to die, 
epinephrine lost its calorigenic action. This indicates 
that failure to obtain a calorigenic response in the ab-
sence of the liver, at l east in the frog, might actually 
be due to a failure of the animal, rat.her than the absence 
of the liver. Corkill's -inj ection of epinephrine was made 
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!f!UCh sooner than Sos kin's -injection and the metabolic rate 
fell faster than in Soskin's experiments. Hunt and Bright 
had shown earlier in 1926 (68 ) that tying off the liver 
of cats did not remove the calorigenic response to epi-
nephrine, although it was significantly lower in the 
controls. Since in the fasted animals the only source of 
hyperglycemia is the liver, epinephrine produced its 
action without a hyperglycemia. The fact that the liver 
was not present in these cats, indicates that the source 
of the calorigenic response was probably from the· Krebs' 
cycle, or from the oxidation of lactic acid. Glycolysis 
is also an exothermic reaction, and thus muscle glycolysis 
could have contributed to the calorigenic response. 
The possibility that epinephrine produced its 
calorigenic response by some other means besides the blood 
glucose increase, first suggested by Boothby and Sandiford 
in 1923 (12) was given due consideration by Cori and Cori 
in 1928 (2 9 ) in their work on fasted rats. They gave epi-
nephrine subcutaneously in a dose of 0.02 mg./100 grn . of 
body weight. They found that 3 hours after the epinephrine 
was injected, th e total body glycogen, with the exception 
of the liver, fell 57 mg. They calculated that if the 
glycolyzed muscle glycogen was completely oxidized, 57 mg. 
should produce an R.Q. of 0.74, while the R.Q. actually 
observed was 0.715. Colwell and Bright (25) also 
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demonstrated that if experiments on cats lasted for 3 hours 
epinephrine infusion produced a fat R. Q. They therefore 
concluded that the increase in oxygen utilization \vas not 
entire ly due to the oxidation of glycogen, a nd suggested 
that it mi ght be the conversion of lactic acid to liver 
glycogen. In a later work in 1931, Cori and Buchvvald ( 28 ) 
expounded upon the mechanism. They explained that TJ1eyerhof 
had shown th<:.lt for each 02 equivalent of 1 mol of l a ctic 
acid used above the basal oxygen consumption, 2-5 mols of 
lactic acid may be reconverted to glycogen. Since epi-
nephrine caused an increase in muscle lactic acid as 
well as a n increase in caloric output, it wa s natura l to 
think of t he two as having some connection. I f there was 
some connection, then epinephrine injection in f rogs should 
cause less lactic acid to appear under aerobic than anaerobic 
conditions. A reference to previous studies s howed this to 
be true. ·whereas anaerobic conditions caused an excess of 
306 mg. of lactic acid per kg. of frog, aerobic caus ed an 
exce s s of 169 mg./kg; thus creating _a difference of 137 mg. 
He calcula ted mathematically that 25.3 cc of oxygen were 
needed to oxidize the part of the excess lactic acid that 
\vG. s slated to become oxidized (4:1). In other words, the 
frog should have consumed an extra amount of 25.3 cc of 
oxygen/kg . to oxidize the lactic acid. They put this to 
the test in i1mnobiliz ed frogs giving 0.05 to 0.1 mg. of 
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epinephrine subcutaneously. They computed that the total 
extra oxygen utilized during the 3 hour period was 2$ cc/kg. 
of frog . This, as can be seen, compared favorably with the 
theoretical 25.3 cc, which he had previously calculated. 
Thus they conc l uded that the effects of epinephrine in the 
frog inducing its calorigenic response '<vas mediated through 
the increased muscle glycolysis causing an increased lactic 
acid production and the subsequent oxidation of lactic acid 
and the reconversion to muscle glycogen. 
However, the lactic acid oxidation provided energy 
for the reconversion of muscle glycogen only in the frog. 
In the mammal, almost the only place the lactic acid can be 
converted to glycogen is in the liver, and it is highly 
probable that in the mammal the source of energy is from the 
conversion of lactic acid to liver glycogen. Cori has con-
sequently sho~vn that the oxidative energy required to con-
vert the lactic acid is derived from fat oxidation in rats . 
He has shown that in the 24 hour fasted rat (29) the in-
crease in heat production is at the expense of the fat 
combustion following epinephrine. He showed this by deter-
mining the urea nitrogen, and finding it unchanged from 
the control, which indicated that the protein was not 
being utilized. The R. Q. of 0.715, when only fat and 
carbohydrate are being used, can be shown mathematically 
to be due 99% to the combustion of fat and 1% to the 
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combustion of carbohydrate . In the following paper (30) 
he describ ed the effect of epinephrine injection i n the 
rat in the postabsorpti ve state, and showed that of the 
total increase of heat production , the breaY.:down of fat 
contri buted most of the calories; t h e increase in fat 
ca l ories ~vas greater than the increase in carbohydrate 
calories. 
In the last paper of this series (31) , Cori 
shmved that in rats which vlere absorbing glucose from the 
alimentary canal, the extra calories foll01ri ng epinephr ine 
i njection v-re r e furn i shed entire l y by f at, ae;::;pit e t.he in-
crease i n blood sugar l evel . There has been t endered no 
expl a nation of t h is phenomenon , and it is not knov·m if 
the epinephri ne affects fat metabolism directly or in-
directly. 
This theory v-rould serve ·co explain some of the 
reports of failure to elici t a large calorigenic res ponse 
in the hepatectomized ani mals . Since the reconversion 
of lacti c a cid takes pla ce only in the liver, in the same 
area as fat oxidat ion, a major source of the calorigenic 
response 1-vould be r emoved v-rith liver ablc!.tion . 
From 1927 to 1939 Griff ith and his colleagues 
publi shed a series of papers dee:1. ling with the effect of 
e pi nephri ne i njected arterially to the hind limb of an 
anest hetized cat (52, 53, 54 , 56). He a s swned that 
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practically all of the epinephrine v..rould be used by the l eg . 
He tried a variety of dosages ranging from 0.002 gamma to 
2 garnma/kg./minute for 5 minutes and found that in all 
cases tjere resulted a decrease in blood flow and a decrease 
in oxygen consumption of the hind limb . He took this to-
gether with his earlier negative ::>tudies in the isolated 
limb and muscle as indicati ng that epinephrine did not 
produce its increased oxygen utilization by acting on 
peripheral tissue. In 1947 Griffith and his co-workers 
(57) shifted t he injection to the intravenous route. They 
injected doses varying from 0. 5-8 gamma/ kg./rninut;-,e for 5 
minutes. They found that the rate of bl ood flow through 
the leg was either increased or decreased, but on the 
average, was increased; maximal ly by the smallest dose 
and lea::;t by the largest . Glucose retention by the tissues 
of the leg was invariably increased as was the lactic acid 
level in the blood, whether flow rette l•l<lS increased or de-
creased. The oxygen utilization of the blood was found to 
vary directly 1,vi th the rate of blood flow. r hey concluded 
that neither a carbohydrate plethora nor an increased 
lactic ac i d output appeared to have an effect on the 
respiratory metabolism of the leg tissueb, at least under 
the cond i tions of jcheir experi ment . 
In 1949 (51), the same workers repeated their 
8A'"Perimenjc, this time incJ_uding a me asurement of arterial 
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blood pressure, leg volume ., and other changes resulting 
from e pinephrine injection and glucose injected in amounts 
sufficient to produce an equivalent hyperglycemia. 
Epinephrine was injected at the rate of 4 gamma/ 
kg ./minute for 5 minutes and glucose at the rate of 50 mg./ 
kg./minute for 5 minutes. They produced a hyperglycemia 
of 77 and 82 mg . % respectively. Gl ucose transfer in the 
leg was increased by 120% by epinephrine and by 88% by 
glucose i ndicating that e pinephrine influences blood sugar 
uptake . The average effect of epinephrine on blood flow 
-v;as to increase it about .3% whi l e glucose increased it 2$%. 
Again the effect was variable. The leg volume decreased 
markedly when the blood flow increased. The arterial 
pressure rose with the blood flow. The oxygen utilization 
again va ried with the blood flow and not with the rate of 
g l ucose uptake. Thus the injection of glucose increased 
the oxygen consumption 19% while epinephrine increased it 
5%. At this time Griffith attempted to explain the 
diverging results. 
He suggested that an increased influx of 
carbohydrate into the tissues of the leg stimulated the 
r (:) s piratory metabolism b y the s pecific dynamic action of 
carbohydrate. Increased C02 f ormation caused vasodilation 
resulting in an increased blood flow and in an i ncreased 
0 2 supp ly . Th is \vas ::>hown by the glucose infusion. 
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In the epinephrine infusion, vasoconstriction 
of varying degrees occurs depending on the tissue con-
ditions in the anestheti zed animal. Arteriolar co-n-
striction could be sufficient to block passage of the 
r ed cells, but still permit a flow of plasma of high 
glucose content. Glucose could then enter the tissues, 
but no 02 would be available for utilization. Variations 
in the degrees of vasoconstriction could then account for 
the variable amounts. However, it should be borne in mind 
that this situation holds for the experimental conditions 
that Griffith used and might not apply to the unanestheti ~ed 
animal. 
The outstanding objec~ion to this theory is that 
one would expe ct an increased 02 utilization in the muscle 
after the epinephrine had worn off. Ho\vever, Griffith's 
measurements extended to 30 minutes after the injection of 
epinephrine and there \vas no indication of a subsequent 
increase in 02 utilization. However , if Griffith's 
postulate is true the decreased 02 presentation to the 
tissues would prevent the oxidation of lactic acid and 
pyruvic acid in the leg and all oxidation would occur in 
the liver; thus, giving an increase in 02 utilization in 
the body as a whole without an apparent effect in the 
limb. Thus, the results of Griffith are not in co1lfli ct 
with the theory of Cori. 
74 
The literature ,dealing with the effect of epi-
nephrine on 02 consumption in vitro presents a confusing 
icture, indeed. As mentioned in t he beginnin~ of this 
discussion, a lmost all or:sans have been tested . .A com-
plete bibliogra . hy is given by Griffith (5 0) and indicates 
that i n almost every tissue epinephrine may cause 02 con-
sumpt i on t o go u p , down, or stay the same. For example , 
the following re ports 
4
resent evidence for increase i n 
02 utilization following epinephrine in the liver: 
Gottschalk (47 , L~8) , Masing (86 ), Nukariya (96 ), Reinwein 
and Singer ( 99 ), Smirnova and Sverev ( 105); and in muscle: 
Ahlgren ( 3 , 4) , and IVIacht and Bryan ( 8J ) • Deivleio ( 87) 
has cla imed that the 02 consumption of liver rema i ns un-
changed after e pinephrine administration and Paasch and 
Reinwei n ( 98 ) , Nakao ( 90) , Schattenstei n and Zyukova ( 104) , 
DeMeio ( 87), and Wa l aas and Walaas (121) have made similar 
cla ims for the effect on muscle. On the other hand , there 
have been the reports of De Cloedt and Van Canneyt ( 21 ) , 
Euler (3 8, 39 ), Neuschlosz (91), and Abderhalden (l) tha t 
e :;i nephrine causes a r i se in 02 consumpt i on in isolated 
liver prepar at i ons. Si milar claims to an increa se have 
been made for muscle by De Cloedt and Van Canneyt (21), 
Klein (76 ), Goor (46 ) and Euler (3 8, 39 , 40). Almost 
a ll of the techniques were very similar and little if any 
explanation ca n be offered f or the amazing va riety of 
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results. In most cases th,e only variable between the 
various experiments was the dosage of epinephrine used, 
but the literature dealing with the effect of the dosage 
of epinephrine on 02 consumption is as confusing as the 
literature cited above. (See Griffith (50) ). Griffith, 
himself, (50), stated that he is , 
" •• • unable to evaluate such evidence except from 
a quantitative point of view; from this stand-
point it may be pointed out again that if those 
results indicating no effect or a decrease in 02 
consumption are set off against those which in-
dicate an increase the first two will be found 
to outnumber the third .. • we have seen no 
acceptable or accepted explanation for so many 
failures to show a stimulatory effect . " 
In view of the fact that Griffith, a renor.med 
investigator in the field, and probably many others like 
him, can onl y use the force of numbers to give weight to 
the answer to this problem, it is ho ped that the data set 
forth in this section will serve to add weight to one sl.de . 
Also, some of the observations made in the experiments 
with epinephrine alone, may give some clues as to the con-
flicting results. 
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INTRODUCTION TO EXPERIMENTAL WORK 
The foregoing review of the literatur~ has in-
dicated that although some or der can be placed in the 
rather confusing results obtained on the effect of epi-
ne phrine on carbohydrate metabo l ism in vivo, the con-
glomeration of results in vitro are so chaotic that any 
experiments which l end weight to one or another side of 
the i ssue are believed to be valuable in a final classi-
fication of the mechanism of action of the response. 
That epinephrine produces a rise in blood sugar is in-
disputable , as is the fact that this rise. is due in a 
l arge measure to the conversion of liver glycogen to 
blood gluc ose. One of the most important questions is 
whether the rise is due, in part , to a failure of the 
tissues, particularly muscle tissue, to remove glucose 
from the blood, and/or to utilize the gl ucose once picked 
up. 
The previous sections of this thesis have un-
covered some interesting observations. First, that the 
adrenergic blocking drugs decrease the hyperglycemia in 
animals, but fail to show any effect on the lacticacidemia 
resulting from epinephrine injections, at least in the dog. 
This may be interpreted in several ways: 
1. The blocking a gent exerts its effect on liver 
glyco genolysis and not muscle glycolysis. 
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2 . If the hypothesis offered above (that epi -
nephrine causes part of the hyperglycemia by decreasing 
the r ate of g lucose uptake and/or gluco se ut ilizati on) 
is true , then the block i ng agents might a ct by removing 
that effect of ep i nephrine . 
3. The blocking agent could reduce the effect 
of epinephrine on both liver and muscle glycogeno l ysis . 
In this case, the failure to b l o ck the lacticaciderni a 
mi ght be due to a circulatory a ccumulation of the lactic 
acid ~1ich i s still being produced. 
The other observation is that ant i h i stami nes 
whi ch had formerly been thought of a s fairly s pecific have 
now been shown to block e pine phrine-hyperglycemia in the 
rabbit, although thi s e f fe ct was not demonstrated by most 
compounds in the dog . One wonders if the effect of these 
ant ihi stami nes might be s pe cies specif ic . 
It 1-".ras thought that one of' tht: best methods to 
shed s ome li ght on thf.:.l answers to s ome of these problems 
was the ~·:arburg techni que f or the study of isolated 
tissues . The rat wus chost:n as the best experimental 
animal , s i nce as Germn i ll ( /+4 ) f i rst advocated , in rats 
vv-e i ghi ng less than 180 grcuns , the diaphragm i s rarely 
thick er them 0 . 5 mm . allo~<'Ting for easy transfer of oxygen 
i n the rea ction f lask . The r at diaphragm has been used 
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~lmost exclusively by other workers for the study of 
muscle metabolism with preparat ions other than mince . 
The experiment was designed to run in the 
presence of a high glucose environment. For this reason 
the tissue was ba thed in a medium containing 200 mg . % 
glucose . The experiment was further designed so that in 
the course of a single experiment on muscle it was possib le 
to measure the glucose uptake, glycogen synthesis and R. Q. 
(hence glucose burned). The summation of all these measure-
ments make it possible to get some insight as to changes 
in carbohydrate balance under the influence of epinephrine 
and under the influence of blocking drugs. Experiments 
measuring the rate of liver glycogenolysis and oxygen con-
sumption were also included, in order to help explain some 
of the effects of the blocking agents . 
The adrenergic blocking drugs, DH0-180 and SY-21 , 
were chosen for study. The former ·was chosen because it 
was effect ive in such lov1 dose in rabbits and was without 
apparent effect in dogs. The latter was chosen because 
it is known to be a potent blockin g drug when tested on 
the other effects of e inephrine, yet only succeeded in 
producing a partial blockade of the hyperglycemia in both 
rabbits and dogs. In addition, it seemed desirable to 
se l ect two chemical types of adrenergic blocking drugs; 
DH0-180 belonging to the ergot alkaloid class, while 
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SY-21 is representative of the 2-haloalkylamine type. 
Neoantergan was chosen as a represent.ative of the anti-
histamines since it was so effective in rabbits, and 
has been considered to be one of the most specific 
antihistamine drugs. 
$0 
l·.L~THODS 
~\. The rat diaphragm . 
:F'or these experi ments male albino rats of the 
Sprague-Dawley strain were used . They vfere supplied by 
r,he Charles River Breeding Laboratory. Only rar,0 vleigh-
ing 85 to 110 gms . vwre utili zed. i: ll animals were 
allowed t o rest as quietly a~ possible for at least one 
hour prior to an experiment . fter all the apparatus 
was prepared <::Lnd the so lur,ions added to the flask, the 
rat was quickly removed from its cage and ki lled by 
decapitat ion . The blood \vas allQI.ved to drain for 30 
seconds , after which a mid-ventral i ncision was made in 
the s kin and the muscle from the urine1ry aperture to 
the clavicle . The diaphragm was freed from the abdominal 
viscera by cut t i ng the hepatic ligament and the other 
omenta close to the diaphragmat i c musculature . The 
sternum was clipped Nith a force ps , and the lateral walls 
of the diaphragm IIIJ'ere freed from the rib cage by cut'cing 
clo se to the inner wall of the r i bs . The sternum was 
then cut , and the diaphragm was freed from the lungs by 
cutt ing the pl eural atr,achments close to t he diaphragm. 
The dorsal wall wa~ freed by cutting close to the dorsal 
body vvall . The diaphragm vms thus removed and placed 
in a petri dish f i lled wiU1 cold phosphate-buffered 
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saline (described below). In order to keep the saline 
cool, the petri dish was rested on an ice bath. The 
central ligamentous portion ~vas carefully dissected out 
together with all other visible tissue other than 
muscle, and then the organ was finally bisected by 
cutting the short connecting strip that attached it to 
the remaining portion of the sternum. To this time, the 
only place the tissue was grasped was by the attached 
portion of the sternum. This method of dissection 
allowed a minimum of manipulation and cutting of the 
diaphragm itself. 
B. The rat liver slice. 
Rats used for the experiments on liver s li ces 
were k i lled by the same method as described above. The 
abdominal viscera were exposed as detailed above and the 
ventral lobe of the liver was quickly excised and im-
mediately placed in a chilled Stadie-Riggs microtome. 
Sections of 0.5 mm. were immediately cut. The first 
section was discarded, and the remaining sections were 
i mmediately placed in a petri dish filled with ice-cold 
phosphate-buffered saline and set in an ice bath until 
the succeeding portions were cut. 
The medium used was a phosphate-buffered saline 
recommended by Tuerkischer and Wertheimer (117) as a 
convenient simple medium which readily supports glycogen 
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synthesis. It consisted .of: 
0.74% saline 
O. 0181~ Na 2HP04 
0.003% NaH2Po4 
Glucose was added to this medium just bef'ore it 
was added to the flasks in amounts such as to have a final 
concentration of 0.2% glucose. This mixture gave a pH 
of 7 . 1 which was altered to 6.95 when epinephrine was 
added. 
The direct method of War burg { 118) \vas used 
to det ermine the rate of oxygen uptake i n an atmosnhere 
02 
of oxygen, Qo2 , and the rate of carbon dioxide production 02 
in an atmosphere of oxygen, Qc02 • To this end, 0.2 ml. 
of 20% KOH was added to the center we l l of those flasks 
02 
which were to be used for the measurement of Qo2 • The 
lip of the well was lined with grease to prevent leakage. 
At this point, the appropriate amount of blocking agent to 
be tested was added and followed by an amount of medium 
sufficient to make a final fluid volume of 2.0 ml. This 
volume included the 0.2 ml. of KOH added to those flasks 
02 
measuring Qo2• The flasks, of course, were all prepared 
before sacrifice of the animals. As soon as the hemi-
diaphragms or liver slices were added to the flasks, 0. 2 
ml. of epinephrine (see below for concentrations) freshly 
removed from the refrigerator, was added to the side arms . 
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The side arms of the con~rol received phosphate-buffered 
sali ne prepared with exactly the amount of acid as 'tras 
used to make up the epinephrine solut i on, so t hat both 
the control and experi mental tubes had ostensibly the 
same acid solut ion added to them. 
Fol lowing 'che comp l etion of these preparations , 
the flasks Wt:Jre attached to the manometers, and thoa entire 
fi'ct i ng was p l aced i n the \'Jarburg water bath 'Which was 
maintained at 37° C. ·The total time from the first decapi-
t. at ion to the last p ldcing of seven manometers and a 
thermobar into the bath was about 20 minutes for the 
experi ments on the d i aphragm , and about 15 minutes for the 
liver experiments. 
I:Jhen all the flask s were in the bath, rubber 
tubes leadi ng from an oxygen supply tank were attached to 
the side arms, and the flasks were flushed wi th 100% 
oxygen for 10 mi nutes . Duri ng this time, the shaker 
a pparatus vms set in mot ion at 90 strokes/minute. After 
10 minutes the oxygen i n l et tubes were removed , all cocks 
were closed, and an a dditional 5 mi nut-es was allowed for 
further equi librat ion. At the end of t his }:>t:')riod, the 
cocks were opened and epi nephrine was tipped in. The 
manometers were then zeroed off and readings were taken 
every 10 minutes for 2 hours in the t:Jarlier experi ments 
and evGry 30 minutes for l hour in the later experiments . 
On a given day, , the manometer setup consist ed of 
a thermobar (for measuring changes due to atmospheric con-
ditions, containing everything but the diaphragmatic 
tissue) two or three pairs of manometers , and two additional 
manometers which were removed immediately after the equili-
bration. It vlas from these last two manometers that initial 
values for muscle glycogen , glucose concentration, and 
liver glycogen were taken. It was believed tha~ this method 
for obtaining initial values v'rould control the effects of 
ha ndling the tissue. In order to further this control, the 
manometers were not always set up in the same order, i.e . , 
the earliest excised tissue was not ahvays placed in the 
first flask. 
The epinephrine used was pure 1-epinephrine base 
'supplied by Parke-Davis, Co . ) . It vms first made in a 
concentration of 1:1000 using distilled water and dilute 
HCl . Further dilutions were prepared from this stock 
solution by diluting with phosphate-buffered saline . In 
order to determine the best dose of epinephrine to be used, 
the following concentrations were employed with the dia-
phragmatic tissue. 
O. M. 
-5 
1.6 X 10 H. 
- 6 
1.6 X 10 f.i . 
-7 
1. 6 X 10 Ivi . 
These concentrations refer to the final concen-
tration i.e., after the epinephrine was tipped into the 
flask. 
N- 9-Fluorenyl-N-ethyl-2-chloroethyl arnine ( SY-21) , 
dihydroergocornine (DH0-180), and Neoantergan were the 
blocking drugs selected for this study. The final concen-
tration decided on was that v1hich vms calculated as equal 
to or slightly below the blood concentration effective in 
blocking or reducing epinephrine-induced hyperglycemia in 
the rabbit, if all the dose injected were equally dis-
tributed throughout the blood volume. These concentrations 
were: 
0-5 SY-21 -- 1 M. 
DH0-180 -- 10-5 M. 
Neoantergan -- 10-4 M. 
Again , these concentrations refer to the final 
concentration after mixing with the medium. The solutions 
of blocking drug were prepared by starting with the dry 
salt in the case of SY-21 and Neoantergan, and a stock 
solution of DH0-180, containing 0.5 mg./ml. They we~e 
prepared fresh and diluted with phosphate-buffered saline 
on the morning of a given experiment and placed in the 
refrigerator until ready for use. 
At the end of one or two hours, the manometers 
and flasks were removed from the bath and the flasks were 
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quickly detached. The tissue was removed, blotted dry on 
filter paper, quickly rinsed in iced phosphate-buffered 
saline, blotted dry a gain and weighed in a Roller-Smith 
balance. The tissue vlas placed in 1 ml. of 30% KOH and 
t h.en the glycogen content determined by the method of 
Good, Kramer and Somogyi (45). The glycogen is expressed 
in terms of wet tissue weights . A 0.2 ml. aliquot of the 
medium was a nalyzed by the micromethod of Somogyi (45) for 
· the glucose concentration and an additional aliquot vms 
reserved for the determination of pH. In early experiments, 
0.1 ml. aliquot was used for the determination of lactic 
acid by the micromethod of Barker and Summerson ( 8) , but 
under these aerobic conditions, there was insufficient 
lactic acid produced to be detected by this metho d in my 
hands. 
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Effect of Various Blocki ng Agents on Epi-
nephrine-Induced Effects on Carbohydrate 
Metabolism in the Isolated Rat Diaphragm. 
l) Effect of Epinephrine 
a) R. Q. - 1 .00 
b) Glucose uptake - increases 
c) % accounted for- decreases 
d) Glucose burned - increases 
e) Glycogen increases - decreases 
f) Glucose utilized - decreases 
Interpretation - The finding that under the influence of 
epinephrine the diaphragm formed less glycogen can be 
interpreted as either a decreased glycogenesis or an in-
creased glycolysis . The work of Tuerkischer and Wertheimer 
( 117), which has been dis cussed above, suggests that the 
latter po~sibility is more nearly correct. Thus , at the 
same time that epinephrine caused an increase in glucose 
uptake it decreased the total amount of the glucose uptake 
which was actually utilized. This indicates that there 
was an accumulation of some intermediate product. The 
evidence presented by other vvorkers suggests that this 
product was hexosemonophosphate (see discussion). 
2) Effect of SY-21 plus ]pineph~ine 
a) R. Q. - 1.00 
b) Glucose uptake - Unchanged 
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c) (., / accounted for - Unchanged j? 
d) Glucose burned 
-
tl 
e) Glycogen increase Tf 
f ) Glucose utilized 
-
!1 
Inter12retation - All t he eff ects of epinephri ne on the 
a s pe cts of carbohydrate metabolism wh ich have been 
measured were blocked by SY- 21 . · 
3) Ef f ect of DH0-180 plus Epinephrine 
a ) R. Q • - l • 00 
b ) Glucose uptake - increased 
c) % accounted for - decreased 
d) Glucose burned - increased 
e) Glycogen increase - decreased 
f) Gluc ose utilized - decreased 
Interpretation - All of the effects of epinephrine on the 
aspects of carbohydrate metaboli sm which have been measured 
rema i ned after treatment vvith DH0 -180. 
4) Effect of Neoantergan plus Epinephri ne 
a) R. q. - 1.00 
b ) Gl ucose uptake - Unchanged 
c) % account-ed for - de crease d 
d ) Glucose burned - i n creased 
e) Glycogen i ncreas e - increased 
f ) Glucos8 utilized - dec reased 
Interpretation - The only explanation that can be offered 
for the failure of the glucose uptake to rise follo'\ving 
epinephrine is the wide variability of the data. It is 
believed that a larger series of experiments would show 
this gluco·se uptake to rise. With the exception of this 
phase all of the aspects of carbohydrate metabolism which 
have been measured persisted after treatment v-.rith Neoantergan. 
If the increase in glucose uptake is found to be truly blocked 
by Neoantergan, it may offer an explanation for the potenti-
ation of epinephrine-induced hyperglycemia seen in dogs. 
If the elevated blood glucose is not removed at an acceler-
ated rate such as is apparent in these experiments, the 
blood glucose will rise still higher. 
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Effect of Grad~d Doses of Epinephrine 
on Oxygen Utilization of the Isolated 
Rat Hemidiaphragm Duri ng the First and 
3econd Hours. 
Interpretation of Results 
Epinephrine in a concentration of 1 . 6 X lo-7 M 
did not alter the oxygen consumption during either the 
first or second hour . However , a ten-fold increase in 
concentration signi fi cantly increased the oxygen con-
sumption during both the first and second hours . A 
hundred-fold increase in concentration, i.e. 1.6 X lo-5 M 
also increased the rate of oxygen consumption during both 
the first and second hours, but did not increase the rate 
above that with 1. 6 X 10- 6 M concentration. It was there-
fore decided that a concentration of 1 . 6 X 10- 6 M of 
epinephrine woul d be used . This concentration has been 
shown by other workers to produce rnaxirnwn glycolysis in 
the isolated liver (107). 
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The Effect of Epinephrine (1. 6 X lo-6 M) 
on Oxygen Consumpt i on of the Isolated Rat 
Hemidiaphragm During the Second Hour . 
Interpretation of Resul ts 
Duri ng the second hour, the rate of oxygen con-
sumption of the control diaph.ragms fell slightly but sig-
nificantly as compc.::tred to "che control rate of the first 
hour . When epinephrine was added to the med ium, the 
mean rate during the second hour was also less than the 
mean rate for the first hour with epinephrine . However, 
the variability in the response was so large, that this 
decrease was not statist ically significant. This second 
hour oxygen consumption rate vvi t h epinephrine wa s still 
significantly higher than the controls during t his period , 
but had fallen to the po int where it v.Jas not signifi c<:mtly 
different from the controls of the first hour . Hence, 
statistically , one cannot demonstrate any difference be-
tween the control rate for the first hour and the rate v-1ith 
epinephrine for the second hour . 
It is ~uggested that this is an indication of a 
begi nning failure of the action of epinephrine so that the 
rate begi ns to approach normal . One clue to explain the 
drop in oxygen utilization is suggested by the R. Q. It 
will be noted r,hat the R. Q. of the controls rose during 
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·c he second hour to l. 07 from l. 00. This suggests a shift 
during the second hour from glucose oxidation exclusively 
to · an oxi dation of glucose with simultaneous fat and/or 
protein storage . It is believed that, in this case, it 
is probably fat . Chernick , Masoro, and Chaikoff (20a), 
using cl4-labeled glucose , have demonstrated that the 
isolated rat diaphragm is capable of converting glucose 
to fatty acids. 'l'he storage of fat during the second 
hour by converting the glucose to fat vrould release some 
oxygen from internal metabolism which could be utilized 
in the place of external, or supplied oxygen . In such 
an instance, the rate of oxygen utilization would tend 
to decrease from external measurements . Similarly, in 
those diaphragms treated with epinephrine, the R. Q. rose 
to 1.04. This can again be explained as above, by the 
storage of fat. It will be noted that in those d i aphragms 
incubated \"lith epinephrine, the R. Q. did not rise to the 
1.07 of the controls. It is likely that under the in-
fluence of epinephrine, there was an accumul ation of 
hexosemonophosphate during the first hour . During the 
second hour , as hc:.ts been hypothesized, the efi'ect of epi -
nephrine begins to decrease, and this hexosemonophosphate 
is then oxidized. Thus, the epinep.hrine-treated diaphragms 
use more oxygen during the second hour than the controls, 
and the H. ~~ . is kept lovmr:. Further evidence in 
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substantiation of the failure of epinephri ne act i v ity 
during the second hour is offered in the section deali ng 
with "Effect of epinephrine on glycogen synthesis in the 
i solar..ed diaphragrn . n 
9!+ 
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Effect of Blocking Agencs on the Calorigenic 
Action of Epinephr i ne in the Isolated Rat 
Diaphragm . 
Interpretation of Result s 
1. The Effect of Epinephrine 
Epinephri ne in a concentration of 1.6 X 10- 6 
mols caused a rise in the oxygen consumption of 0 .27 
ml ./gm ./hr. Thi s was e quivalent t o a rise of 24.31; over 
t he control value. This experiment was designed, f or t he 
most part, as a paired data experiment . However, it was 
noted that although there was a variability in the re-
sponses between the halves of the same diaphragm , t,hose 
diaphragms treated with epinephrine consistently used 
more oxygen than those without epinephrine. 'rhe possi-
bili ty that this effect was due to the slight acidity of 
·che epinephrine, was r uled out by preparing a so lui:jion 
of diluting fluid alone , 11ith as much acid added t o it 
as was added to the epinephrine . The experiment 11'las also 
controlled so that those diaphragms receiving epinephrine 
were not dlvvays prepared in the same position, i.e., con-
trol and experimental tissues were prepared alternately. 
As many factors as could be thought of were controlled so 
that this increase in the oxygen consumption due to epi-
nephrine is believed to be a _ specific effect . A series of 
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experiments was performed to determine the R. Q. of the re-
act ion, and since the R. Q. was almost 1.0 in every case, 
the increase in oxygen consumption is considered to be a 
reflection of the burning of glucose. 
2 . The Effect of SY-21 
It was noted that SY-21 in a concentration of 
lo-5 Ivi did not alter the normal rate of Oxygen consumption. 
When epinephrine was added to the medium, the mean oxygen 
consumption rose 0.10 ml./gm./hr. This represents a mean 
increase of 9 .0% over the rate with SY-21 alone. This 
difference was not significant. The tissue treated with 
SY-21 and epinephrine used only 1/3 as much oxygen over 
the controls as did the tissue treated with epinephrine 
alone. This difference was significant. Since no differ-
ence could be shown betvv-een the oxygen consumption of the 
diaphragm treated with SY-21 and epinephrine and the un-
treated diaphragm, it may be concluded that SY-21 reduces 
the calorigenic effect of epinephrine in the isolated rat 
diaphragm to the point of complete blockade. 
3. The Effect of DH0-180 
This dihydrogenated ergocornine in a concen-
tration of lo-5 M exerted a significant calorigenic action 
on the isolated muscle. It raised the mean oxygen con--
sumption 13.8% above the control values. This increase 
in oxygen consumption brought the value to almost that in 
response to epinephrine in the otherwise untreated tissue. 
\'ihen ep inephrine vrds added to a DH0-180 t reat ed di aphragm , 
the mean oxygen cons tunption was raised an additional 13 . 61b 
to produce a s i gni ficant increas e over the rate with the 
DH0 -180 alone . The rate, however, did not signifi cantly 
exceed that of the epine phrine alone despite the calori -
genic activity of DH0 -180 alone . This means that with 
respect to the tot a l increase in oxygen consumption re -
sulting from epi nephrine , there was a partial reduction 
produced, i . e., from a mean 24 .3% i ncrease to a mean 
13. 6% increase. Ho-vvever , a complete inhibi"cion , obvious-
ly, did not occur. 
4 . 'l'he r!:ff'ect of' Neoantergan 
Thi s antihistami ne , in a concentration of 10-4 l'i 
did not signi ficantly alter t he rate of oxygen consumption 
of the i solated muscl e . ~vhen epinephrine V>Tas added to 
the Neoantergan treatf.'~d diaphragm, the oxygen consumption 
i ncreased 14.7%. Here again t h ere i s the suggestion of 
a partial reduction in the calori genic eff ect, ie., from 
24 .3% to 14.7%, but no suggest ion of a comp l et e blockade . 
Summary - SY-21 ( 10-5 !VI ) complete -· y blocked the epinephrine-
induced calorigenic effe ct in the isolat ed musc le . There 
i s a suggestion that DH0-180 ( l0-5 M), itself sli ghtly 
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calorigenic, produced a pq.rtial blockade, but the blocking 
inf l uence of this compound on the oxygen consumption of 
the diaphragm is not believed to contribute considerably 
to the reduction of oxygen consumption in the intact 
animal. This opinion is offered in view of the obser-
vation that the oxygen consumption of the diaphragm treated 
with DH0-180 and epinephrine was ·not different from that 
of the tissue treated with epinephrine alone. Similarly, 
the results with Neoantergan (10-4M) suggested that this 
drug produced a slight reduction in oxygen consumption in 
epinephrine-treated diaphragms. 
Treatment 
Control 
Effect of Graded Doses of Epinephrine on 
Glycogen Synthesis of the Isolated Rat 
Diaphragm During . Two Hours of Incubation 
if of 3Glycogen pl pl 
Expts value after vs. vs. Epi . 
2 hrs. control 1.6 
mgjgm2 X lo- 7:M 
10 3.47 t.. 0.30 
Epinephrine 5 3.40 )0.05 
1.6 .). 0.24 
X l0-7Ivi 
Epinephrine 9 4 .24 
f:. 0 . 27 
(0.01 
1. 6 6 
X 1o- rvr 
Ep i nephrine 5 4.24 
f:. 0.25 
( 0.01 
1.6 
X 1o-5M 
1 - np rr - group analysis 
2 - Wet weight of tissue 
3 - Expressed as glucose 
<' 0. 01 
( 0.01 
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pl 
vs. Epi. 
1.6 6 
X 10- Ivi 
>o. 5 
Effect of Graded Doses of Epinephrine on 
Glycogen Synthesis of the Isolated Rat 
Diaphragm During Two Hours of Incubation. 
Interpretation of Results 
The influence of graded doses of epinenhrine 
on the alteration in glycogen after two hours incubation 
paralleled the influence of graded doses of epinephrine on 
oxygen utilization. That is, 1.6 X lo-7 M was without 
effect and a ten-fold increase showed a significant effect. 
A hundred-fold increase caused no greater effect than a 
ten-fold increase. 
The apparent discrepancy, i.e., more glycogen 
with epi nephrine than without it is believed to be a 
time factor and is discussed under the section dealing 
with "Effect of epinephrine on glycogen synthesis in the 
rat diaphragm". 
The data concerning the effect on glycogen to-
gether with the effect on oxygen utilization were re-
sponsible for the final decision to use epinephrine in a 
concentration of 1 . 6 X 10-6 M. 
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'rhe Effect of Blo.cking Agent s of Epinephrine --
Induced Effects on Glycogen Synthesis in the 
Isolated Rat Diaphragm. 
Interpretation of Results 
l) Effect of Epinephrine 
/ 
A concentration of enine•Jhrine of l. 6 X 10-0 M 
..!.. .... 
caused a mean reduction in the total glycogen value of 
' d! 24.8%. This was a true reduction . It is i nteresting to 
note that there was a mean increase in oxygen consumption 
of 24.3% which, since the R. Q. was 1.0, presumably was 
used to burn glucose. This leads to the speculation that 
the glucos e which would have gone to glycogen was oxidized 
instead, under the influence of epinephrine. It is not 
possible to tell whether this reduction in total glycogen 
after one hour, represents a decrease in glycogen synthesis 
or a splitting of glycogen already formed. 
It was noted that if incubation were allo~"led to 
continue for an additional hour , i.e. for two hours, that 
there was a peculiar shift in the glycogen synthesis 
values. The control value for glycogen changed from a 
value after one hour of 5.13 .J. 0 .17 mg . /gm., to one of 
3.47 ± 0.30 after two hours of incubation . On the other 
hand, the glycogen value of diaphragms treated with 
1 .6 x 10-6 ~ of e pinephrine shifted from a glyco gen value 
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of 3.86 l 0.31 mg.jgm. after one hour, to 4.24 i 0.27 after 
two hours of incubation. Thus, after two hours of incu-
bation, there is apparently a reversal of the effect of 
epinephrine. It is possible to explain this discrepancy 
by the hypothesis previously offered that the effect of 
epinephrine starts to wear off after one hour of incu-
bation. The mass of hexosemonophosphate which had been 
accumulated during the f irst hour (l/3 of the glucose taken 
up may have been in this form) is now available for oxi-
dation. Therefore, it becomes the precursor for glycolysis 
i nstead of mus cle glycogen. The glucose which is taken up 
during this second hour of incubation, is now probably con-
verted to musc l e glycogen . The control diaphragms, hmvever, 
cont i rme to call upon their glycogen reserves for glycolysis . 
A similar situation was observed by Cohen (22) who noted 
that the muscle glycogen of the epinephrine-treated diaphragms 
did not decrease as did the glycogen of the untreated dia-
phragms during incubation. 
2) Effect of SY-21 
A concentration of l0-5 l\1 of SY-21 itself reduced 
the total mean glycogen value of the isolated diaphragm 
after incubation 8 .0%. This reduction did not reach the 
level of the reduction produced by epinephrine. When epi-
nephrine ~ras added to a diaphragm pretreated with SY-21, 
there was again a mean reduction of 8 .2% of t he untreated 
102 
diaphragm bringing the total glyco gen level almost exactly 
to t. hat with SY-21 alone , vJhich left it ;:;t ill hi gh.;;;r than 
that with epinephri ne alone. It may be concluded that ul-
though SY-21 i tse l f caused a decr~ase in glycogen synthesis, 
it completely blocked the effect of epinephrine in this 
response . 
3) Effect of DH0-180 
DH0-180 in a concentr ation of lo-5 Ivi produced a 
mean reduction in the tot a l glycogen value of 8 . 6% of t he · 
control value . It should be r eca lled that a mean increase 
of 12 6% i n ~che oxygen consumption was also produced. This 
de creas e in glycogen synthesis was not as l ow as that pro-
duced by epinephrine . When e pinephrine was added to the 
DH0 - 180 treated diaphragm, an additional reduction of 
21. 8?~ in the mean glycogen value occurred. This approaches 
t he reduct ion of 24. 85b seen with epinephrine alone . 1-
though t h e final mean total value for the glycogen follo-v.r-
ing DH0 -180 and epinephrine is 4-9~ less than that with 
epinephrine a lone , this decrease is not s tati;:;tically 
significant. It may be concluded that the epinephrine 
fa ctor i n glycogen synthesis was not i nflu en ced by 
DH0 -180 in the isolat.ed muscle. 
4) Effect of Neoantergan 
Neoantergan in a concentration of lo-4 M reduced 
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the mean total glycogen va)-ue 10. 27; of the corrcrol value 
which was not as lov.r as that produced by epinephrin • 
The addition of epinephrine to a diaphragm pretreated 
with t he antihistarninic caused an additional mean re-
duction of 26 . 7~&. This should be compared with the 
reduct i on of 24 . 8% due to ep in~phrine in an otherwi s e 
untreated diaphragm. The combi ned effect of a 10.2% 
reduction due to Neoantergan and the 26. 7?~ reduction due 
to the addition of e pinephrine, brought the final glyco gen 
value belovl that found wit h epi nephrine in an otherwise 
untreated di aphragm . Thus , it may be concluded that 
Neoantergan does not reduce the epinephrine factor in 
glycogen s-y-nthesis, and may actually potentiate it. 
Summary 
:C:pinephrine caused a reduction in glycogen 
synthesis. ~Y-2 1 (lo-5 h ) blocked the epinephrine in-
du ced eff ect on glycogen synthesis, al'chough it itself 
r educed 'che glycogen synthesis. DH0-180 and Neoantergan 
themselves reduced the rate of synthesi s and did not 
influence the action of epinephrine. 
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The _u;f fect of Var_ious Blocking Agents on 
.Spinephrine-Induced Calori genic .8ffect on 
the Isolated Rat Liver Slice. 
1 ) The Effect of ~inephrine 
Like the eff ect in the iso l ated muscle prepa-
ration, epine phrine ( 1. 6 X 10-6 Ivl} si gnificantly increased 
the oxygen consumption of the liver slice . This increase 
vvas 22 . 4% over the control value. 
2 ) The ~ffect of DH0-180 
This derivative of ergocornine did no t ~ignifi-
cantly alter the resting oxygen consumption of the liver 
slice. It was found to completely block the epinephrine-
i nduced increase in oxygen utilization. 
3 ) The ~ffect of SY-21 
This 2-halogenated ethylaraine, used i n the s ame 
con centration as was used in the isolated muscle preparation, 
s howed a significant blockade of the epinephr ine-induced 
ca lorigenic eff ect on the liver slice. Actually , however, 
this sh ould be considered a reduction in the respo nse rather 
than a blockade. It will be noticed from the stutisti cs 
that the drug alone did not significantly increa se the r est-
ing oxygen consumption . ~Jhen ep inephrine was added to the 
SY- 21 treated diaphragm , the oxygen· consumption rose 12 . 71~ 
a bove that of "che control_ rate. Although this was not 
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signi f icantly dif 'erent fron the rate vvith SY- 21 alone , it 
is significantly greater than the rate wi thout any d.rug 
added . 
In order to test if t his effe ct mi ght be due to 
the halogenated ethylamine grouping , SY- 73, an hydroxy-
lat ed et hy l amine was tested . This a gent is without 
adrenergic blocking activity in the intact animal and did 
not block the epinephri ne - calori genic effect on i so l ated 
l iver. 
4 ) Neountergan 
Neou11tergan was tested in a concentration of 
10-4 M, the same concentration as vvas used i n isolcLted 
musc le studies . It was wi thout any appreciab le eff e ct on 
the calori genic action of epi ne phrine . This concentration 
v1a s t he same a s would exist in the animal if 3 mg . / kg . were 
injected and all of it we re evenly distributed t-hroughout 
the blood. In order to see the eff ect of a larger concen-
tration , 2 L lo-4 M was added to the preparation, and again , 
there was no effect on the increase in oxygen consumption 
follov>Ting epinephrine. 
Sumrnarz 
Epinephrine ( 1. 6 X 10- 6 r.I) caused an increase in 
the oxygen utilization of i solated r at liver sl ices . DH0-180 
completely bl ocked the effect of e pi nephr i ne . .3Y- 2 1 
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significantly reduced the . response to epinephrine but did 
no·c complete l y block it. SY-73, not an adren~rgic block-
ing drug, but an agent with the ethylarnine grouping was 
witb.out effect . Neo antergan was without eff'ect even in 
doses larger than that 1J·.rhich vmuld usually be i n j e ct:. ed 
into the intact animal . 
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The .Gffect of V.arious Blocki ng Agents on 
Epinephrine- Induced Glycogenolysis in 
the Isolated Liver Slice of the Rat. 
l) Effect of Epinephrine 
Epinephrine (1.6 X 10-6 M) reduced the liver 
glycogen by 4Lh9% of the conJcrol value after one hour . 
2) Effect of DH0-180 
DH0-180 completely blocked the glycogenolytic 
effect of epinephrine on the iso.laJced rat liver. It should 
be noted that this compound was withou"c effect on the iso-
lated muscle preparation. These data suggest that DH0 -180 
is selective in its act ion on the liver . From this , one 
may infer that the blockade of epinephrine- induced hyper-
glycemia in the intact rabbit, with this agent, is due to 
its effect of preventing liver glyco genolysis due to epi-
ne phri ne . This logically would result in a complete 
blockade of the hyperglycemia such as vms seen in rabbits. 
Even though the effect of epinephrine in muscle was present , 
the only way it could contribute to the hyperglycemia was 
to send lactic acid to the liver for glycogenesis. However , 
at the liver the glycogenolys i s of this new gl ycogen, even 
if it vvere f'onned would be blocked by DH0-180 . 
3) Effect of SY- 21 
SY- 21 i n a concentrat ion of lo-5 l•I caused a 
10.8 
significant reduction in the glyco genolysis due to epi-
nephrine. SY-73, an ethyli..lilline compound without adrenergic 
bl ock i ng activity in the intact animal, was without eff ect. 
In view of the combli1ed results of the effects of SY- 21 in 
liver and muscle, it is suggested that the pri mary a ction 
of SY- 21 is on the muscle. Some glycogenolysis is still 
present following epinephrine in its action on the liver. 
'r his may explain ,vhy SY-21 succeeded in only reducing 'che 
e pinephrine-induced hyperglycemia in rabbits and dogs and 
not completely blocking the response as did DH0-180 i n 
rabbit s . The primary cause of the epinephrine-induced 
hyperglycemia is probably its effect on the liver. The 
effect on muscle probably only serves to sustain the 
effect . If a given agent blocks the effect of epinephrine 
on the muscle but only reduces the effect on the liver, 
it is logical that it will only reduce the hyperglycemia 
and nqt completely block it. 
4) Effect of Neoantergan 
This antihistamine, in a dose of lo-4 I'vi and 
2 X lo-4 M, the latter being a very high concentration, 
was 111fithout effect on the liver glycogenolysis due to 
e pi nephri ne. 
Summary 
Epinephrine causes a glycogenolysis of the 
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isolated l iver slice. Th~s effect is blocked by DH0 -180 , 
indica ting that there is a selective o.ction for DH0 -180 
on the liver i n this res ponse. It is suggested that it 
is through its a ction on the liver that this a gent causes 
complete blockade of epinephrine-induced hyperglycemia i n 
the intact rabbit. SY- 21 succeeded in reducing the re -
sponse of epinephrine. Tl1is suggests that the complete 
blockade i1 mus cle in addition to t he reduction of the 
effect in liver is reponsible for the reduction rather 
than the complete blockade of epinephrine- induced hyper-
glycemia i n the intact rabbit and dog . SY-73 , an agent 
without adrenergic blocking a ction was wi thout. effect i n 
this response . Neoan'Gergan , an an'Gihistaminic eff8ctive 
in reduci ng the hyperglycemia of intact rub bits, was \'Ti th-
out effect on the isolated rat tissues even in large doses. 
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DISCUSSION 
In the isolated diaphragm, the experiments 
dealing with the effect of graded doses of epinephrine 
indicate that a maximum effect is achieved with a dose 
of e pinephrine corresponding to a concentration of 
/' 
1. 6 X 10-0 Ivi . This concentration is the same as that 
found to produce maximum glycolysis of the isolated 
liver slices by other workers (116). 
Under the conditions of this experiment, where 
200 mg . % of glucose was supplied to the diaphragm of an 
unfasted rat at the beginning of the experiment there 
;,vas an increase in the rate of oxygen utilization during 
the first hour of incubation with epinephrine. This 
increased rate was apparently due to an accelerated 
burning of the carbohydrate, since the R. Q. was 1.0. 
During the second hour of incubation, the rate of oxygen 
utilization was still elevated in the epinephrine-treated 
diaphragms, but the elevation was less than during the 
first hour . A clue to the me chanism of this decreased 
rate ;,vas supplied by the R. Q. ;,-Jhich rose to a figure 
above 1.0 during the second hour period , indicating 
storage of fat and/or protei n . In such an i nstance, 
oxygen would become available from the raetabolic con-
version of glucose to fat or protein, and "'muld be 
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utiliz ed for further oxidations . Ext E:.~rna l measurements 
would , therefore , indi cate a de creased rate of oxygen 
consumption, although the tissue may be respiring at the 
same rate. Although the conversion of carbohydrate to 
fat is usually thought of as oc curring in the liver, 
Chernick et al . (?Oa) have shown that the isolated rat 
diaphragm is also capable of converting cl4- l abeled 
glucos e to fatty acids . 
~ ine~hrine also caus ed a decrdase in ~lvco~en 
£ ~ . 0 J 0 
synthesis during the first hour of incubation . In the 
presence of glucose in the medium, sucn as there \vas in 
these experiments , thi s mi ght be due to a decrea~ed 
conversion of gluco::; e "GO glycogen , or an i ncreased 
glycogeno lysis . The studi es of Tuerki ~cher and 
~ertheimer ( 117) demonstrat ed that "Ghe increase in 
glycogenolysis with epinephri ne , in the absence of 
g lucose in the medium, was almost the same as "Ghe de-
crease in glycogen synt hesis with glucose in the liledium. 
'Therefore , it is likely Ghat at l east part of the apparent 
decrease in glycogen synthesis was a reflection of an in-
crease i n gl ycogenolysis . 
3utherland ( 115) , in a re ce:nt review of his 
stud ies on the influence of epinephrine in phosphoryl ase 
systems in l iver and muscle , has directed attention to 
evidence tha t ep i ephrine exerts its prime effect on the · 
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phosphorylase of the tissues. The amount of active phos-
phorylase found in tissues represents a balance between 
inactivation and resynthesis of phosphorylase. Suther-
l and and Cori ( 116 ) , Walaa s and Vlalaas ( 121) , and Ellis, 
Anderson and Turtle ( 37), have demonstrated that the 
amount of active phosphoryl ase in is.olated liver and 
muscle tissue treated vvith epinephrine is markedly in-
creased. It was suggested, in view of the fact that 
epinephrine does not inhib it enzymatic in~ctivation of 
hosphorylase as does fluoride that i ts mechanism of 
action was to actually promote the synthesis of this 
enzyme . 
The further interesting fact is that the 
direction of the phosphorylase activity is apparently 
r eversed, i . e., the reaction proceeds mainly in the 
direction of glycogen breakdo\~1. That the addition of 
e pinephrine to isolat,=d muscle and liver results in a 
glycogen depletion is too well known to warrant documen-
tation. Hegnauer and Cori (64) clearly demonstrated 
that the increased glycogen breakdown in frog muscle 
incubated anaerobically with epinephrine was accompanied 
by an accumulation of hexosephosphate and a corresponding 
decrease i n i norganic phosphate . Riesser (100) and the 
Walaases (121) also showed that there was this apparent 
reversal in direction of phosphorylase effect in isolated 
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~at di aphragms . The ex _eriments reported herein do not 
conclusively demonst rate an increased glyc o~enolysis 
i n the - resenc e of gl uc o::;e i n the medium, but they do 
show t hat under the::;e conditions , epine phri ne caused a 
decrease in glyc ogen s ynthesis . Th i s , coupl ed with a 
ce crease i n the mnount of glu cose account ed fo r, suggests 
t hat ep inGphr ine cau s ed a n accumulation of interrn edia·ces 
other than glycogen in these experi ments . The postulate 
that the direction of phos phorylase a ctivity is revers~d 
whe n the tissue is under t he influence of epi nephrine , 
together v.rit h t he result s of 'l'uerkischer and -,Jert he i mer 
(117) would indicate t hat glyco geno lysis contributed to 
part of t he::>e i ntermediates . 
Thu s , evidence has been pr esented by other 
workers that the r e i ::> an accumulation of hexo semonophosphate 
f ollowing epinephr i ne admini stration to an i solated muscle . 
If one postulates that the a ction of ep inephri ne begi ns 
to wear off during the second hour , t he diaphragm , duri ng 
t ll is period, would have a substHnt h tl t:uno1.mt of hexos ernono -
p ho s phat e availab le fo r oxidation, while t- he m1t reated 
dia hra~m would stil l need to call upon its reserve of 
o lyco gen . Thus , during the sec ond l our period, the con-
t ro l diaphragms would be us i ng glyco gen at <.1 faster rate 
than the e pine?hri ne -treated tissues and would account for 
r eversal in the glycogen pat tern . Fur t her evidence 
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pointing to this postulate of a lessening of r,he action 
of epinephrine during the second hour is afforded by the 
R. Q. during this period. Whereas the R. Q. of the control 
tissues rose to 1.07, that of the epinephrine treated dia -
phragm rose to only 1.04. A release of the stored hexose-
phosphate would require additional amounts of oxygen for 
oxidation, and hence would still be using l a rger amounts 
of oxygen than the control tissue even though fat storage 
were occurring, resulting in a lower R. Q. than the con-
trols. 
We have succeeded in this experiment in account-
ing for only 2/3 of the glucose removed from the medium 
by the diaphragm treated with epinephrine in terms of 
glyco gen and oxidized glucose. These fi ndings indicate 
that the remainder of t he glucose is in t he form of one 
or more intermediate products. 
Epinephrine was found to induce a sli ght but 
significant rise in glucose uptake by the isolated dia-
phragm . It is not known hovv important this increase is 
to the entire animal organism. At first glance it seems 
surprising that the epinephrine should increase the uptake 
of glucose at the same time as it decrea ses the total amount 
of glucose utilization. Hmvever , further examination re-
veals that although the total amount of glucose utilized 
is decreased, the amount of glucose oxidized is increased, 
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and the decreased utilization is at the expense of 
glycogen formation. This effect is, actually, a process 
whi ch mak es more energy available to the tissue. Teleo-
logically, we may consider this action of epinephrine 
on the muscle during conditions of stress as one vvhich 
not only increases the total energy output, but al0o i n-
creas es carbohydrate reserve of the tissue in cet.se the 
supply of carbohydrate should for some reason be de-
creased . 
1/alaas and Ualaas ( 121) , performed an experiment 
very s i milar to the one reported here '\vi Jch epinephri ne 
and rat diaphragms. For an unknmvn reason the results 
wi th oxygen consumption and glucose uptake conflict with 
our O'l:vn results. It was noted in our experiments t hat 
the oxygen consumption and the glucose up~ake increased 
in every case when the diaphragms were incubated 1-vith 
epinephrine . However, in the · ~laases' experiment there 
was noted a decrease in the glucose upt ak e and no change 
in oxygen consumpt ion. However, these workers also f ound 
that there was less glucose accounted for in the epi-
nephrine-treated diaphragms than in the controls. One 
wonders if t he d ifference i n results could not be 
a'ct ributed to the time spent before incubation amounting 
to l/2 to 3/4 of an hour and the difference in measure-
ment of initial values. Their initial values were taken 
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before equilibration started. In our own experiments the 
initial values were taken just after equilibration and 
before incubation. 
In the liver, it was noted that eninephrine also 
exerted this ca lorigenic actiOn of about the same magnitude 
a s wo.s found in muscle. The cle.ssic .~ lycogeriolytic action 
of epinephrine on the liver was also quite evident. 
In addition to the report of Von Euler (3 8) who 
found that ergotamine blocked th~ calorigenic effect of 
epinephrine on minced frog muscle, there have been some 
reports on the effect of adrenergic blocking drugs in 
reduc ing the increase in oxygen consumption when epi-
nephrine was administered in vivo. Cappo (16) and 
Orestano (97) obtained negative or doubtful results with 
ergotamine in the intact man and rat. On the other hand, 
Harangezo-Oroszy (59) demonstrated positive results i n 
the anesthetized rat. Lundholm, in 1949 (82), gave epi-
nephrine in the dose of 20 gamma/kg. subcutaneously to 
cats and blocked the calorigenic effect with ergotamine, 
in a dose of 20 gamma/kg . intramuscularly, which did not 
itself lower the oxygen utilization. In a later \I>Tork (81) 
he found that 200 gamrna/kg. of ergotamine intramuscularly 
was necessary to block the effect of 20 gamma/kg. of nor-
epinephrine. That dose of ergotamine, however, produced 
a decrease in oxygen consumption. He concluded from his 
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experi ment tlmt since the dose of ergotamine which block ed 
epinephrine did not lmver oxygen consumption in the ab -
sence of epinephrine, and doses of ergotamine vd1ich blocked 
nor-epinephrine did , that nor - epi nephrine i s actually the 
sympathet ic mediator . His conclusi on is rather queer 
since be tested only 2 doses of ergotc.unine , 20 e;amwa and 
?00 P'''l ""'rl} ':)/lrg· 
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De Vleeschhouwer (120 ) showed that Dibenami ne , 
SY- 2$ und SY-30 will all block the calori ~enic action of 
e pine~hrine und no r-epinephri ne in dogs which are anes -
thetized . No doses uf b locking drugs wer~ reported . 
Issekut z , a German ( 70) , has shovm . that DH0-180 
and DHE-45 are witho ut effect in reducing the calorigenic 
action of e pinephri ne i n anesthetized rats . 
The only repor t found deal ing \vi·ch the effect of 
i..l haloalkylami ne in vitro was that of Harvey, \lang and 
Nickerson ( 61) \vho studied the effect of u 2- haloalkylam ine, 
SKF 688A , on rdouse liver homo genates treated vii "ch epi-
nephrine. The glyco enolys i s and glucose production v,rere 
measured and it was found that the increase in these 
effects produced by epinephri ne was blocked by graded 
do ses of the block ing drug rangi ug from 10-40 gamma/ml . 
The de gree of blockade was . roportional to t h e dose used . 
In the ~Jrevivus se ction of t h is tl esis, it has 
been su~ges~ed , in view of the data obtained, t hat the 
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influence of adrenergic blocking and antihistmnine drugs 
on epinephrine-induced e.ff ects on carbohydrate metaboli s m 
may va ry from s pecies to species. There.fore, the results 
of experiments v·rith r<.:.'..t tissues in vitro should be con-
sidered as possibly being specific .for the rat . It is 
also necessary to emphasize that conditions in vitro only 
simulate, and by no means exactly reproduce , the con-
ditions in vivo. The writer is aware o.f the dangers in 
explaining results in vivo by observations made iri vitro . 
Even more dangerous is an explanation of the results vvi th 
one s pecies obtained in vivo with the observations made 
v-rit h another species in vitro. However, the results ob-
tained with the isolated tissues of the rat make . it 
possible to s p ecula'ce on the various factors producing 
the results found in the intac'c rabbit and dog. There-
fore, the fo l lovdng discussion of rnechanisr.ls should be 
regarded only as speculative , and no"'c as factual ex-
planations. 
The influence of SY-21 on these responses to 
epinephr ine suggests an explanation for the eff ect of 
'chis a gent on epinephrine-in duced hyperglycemi a i n rabbits 
and dogs . It will be remembered that SY- 21 , although a 
potent adrenergic blocking a gen t, even in a dose of 2mg ./ 
kg . succeeded only in reducing the hyperglycemia o.f both 
rabbits and dogs . In the _isolated rat tissue, it was 
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notea that , whereas SY- 21 completely blocked the response 
in musc le , it only partially blocked the effect in liver 
tissue . Since t he hyperglycemia produced by e pinephrine 
is probably due primarily to the liver glycogenoly~is , 
( -:.he rauscle effect s serving to sustain the action by 
restoring liver glycogen from lactic acid) a partial 
blockade of the liver processes ~<vould, logically, only 
result in a partial blockade of the hyperglycemia. Since 
SY-21 blocked the effects of epinephri ne in isolated rat 
muscle , t he failure for this a gent to redu~e epinephrine-
induced lacticacidemia in dogs j_s sti ll an open question . 
Although , species specificity should be considered, a 
circulatory factor should a lso be considered. \vith a 
dose as large as 2 mg . /kg . of SY-21, t he injection of 
epinephrine would result in a decrease i n blood pressure, 
and probably in c>orne resultant pooling of b lood. This 
vvoula allow an acctunulation of lactic acid ::;o that when 
measured , it would appear hi gh8r thaa normal . This l utr,er 
explanation wo uld give some clue to the failure of the 
agents used in the dog to block the lacticacidemia pro-
auced by e pinephrine injection . 
The first supprebs i on of the glycog8nolytic 
e ffect of epinephrine in vitro was accomplished by Frolich 
and l:-'ollack ( 43 ) ana lviori ta ( 89 ). 'i'hese workers sue ceeded 
in blocking the glycogenolytic effect of epinephrine in 
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ergotoxin perfused livers.. Houssay and Gersc . .hrnan (67) 
successfully produced the blockade in a similar experiment 
using ergotamine and dihydroergotamine. Tuerkischer and 
Wertheimer (117) using incubated rat diaphragms produced 
a blockade of the glycogenolysis with ergotamine. How-
ever , Hegnauer and Cori (64) were unable to block the 
increase in lacti c acid and hexosemonophosphate production 
in isolated frog muscle with ergotamine. In their experi-
ments, the muscles were incubated in a nitrogen atmosphere. 
Ellis , Anderson and Turtle (37) studied the 
effect of epinephrine on l iver slices from rats and rabbits. 
It was found that there was a marked increase in glucose 
liberat ion and phosphorylase activity "vhen the slices were 
incubated with epinephrine. Rabbit liver slice s gave a 
larger increase in these reactions than the rat liver 
slices. It was found that dihydroergotamine blocked the 
effects of epinephrine in the liver. 
The action of dihydroergocornine, which gave a 
suggestive reduction of the increase in oxygen utilization 
induced by epinephrine in the diaphragm, and a complete 
blockade of all the effects measured in the liver, gives a 
clue to its mechanism of action in the intact rabbit and 
rat (3 6) . If, again, the primary cause for hyperglycemia 
in the intact animal as a result of epinephrine injection 
was the outpouring of glucose from the liver , then 
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blockade of the lysis qf liver glycogen should result in 
a complete bl ockade of the hyperglycemia. Since the 
effect on muscle only sustains the hyperglycemia by 
replenishing glycogen from lactic acid, then this new 
glycogen is also blocked by DH0-180 and hence the blood 
sugar would still not become elevated. 
Neoantergan was fouhd to be an ef fective block-
ing agent of epinephrine-induced hyperglycemia in the 
rabbit, but in these experiments in the rat it was found 
to be without blocking activity, . even in high concen-
trations. Indeed, its action on isolated muscle tissue 
indicated that it mi ght potentiate the effects of e pi-
nephrine by increasing the rate of glycogenolysis and 
decreasing the rate of glucose uptake. These latter 
effects suggest some explanation for the action of some 
antihistamines to potentiate the hyperglycemia in dogs. 
One is forced to conclude that the blocking action of 
this antihistaminic agent in the rabbit is due to some 
non-specific action or to some effect on carbohydrate 
metabolism which is rabbit specific. The action of 
Pitocin, Pitressin , and ephedrine to inhibit epinephrine-
i nduced hyperglycemia in the rabbit, suggests that the 
rabbit may be sensitive to agents which produce circulatory 
changes. The ability of several antihistamines to poten-
tiate the pressor effects of epinephrine, suggests that 
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in the presence of e pinephri ne these agents also induce 
circulatory changes, vvhi ch mi ght have some effe ct on 
curbohydrate met abolism in the rabbit . Ot her such non-
s pecific mechanisms i n which ca rbo hyd r ate met abolism is 
' 
only i ndirectly affected can be postulated, but the proof 
for any such mechunism is still lacking . 
GJ~N SH.AL SUMHAHY AND CONCLUSIONS 
';Jhen epinephrine is injected into an intact 
animal, one of the cha racteristic changes that can be 
obs€~rved is an hyperglycemia. There are tv.ro possible 
mechanisms by which the blood sugar could be increased 
in the fasted animal . The first is an incr ease in the 
rate of liver ~lyco genolysis which re l eases glucose into 
the blood stream. The s econd is a decreased rate of 
gluc ose uptake by the ti s sues whi ch results in an ac-
cumulat i on of glucose in the blood stream. The a ction 
of e p ine phrine ha s been postulated to be on both of 
these me chanisms . 
It has been suggested that the pro cess referred 
to in the literature as glucose utilization should be 
considered as two separate pro cesses. The first has been 
t ermed "g lucose uptake" , and v.ras defined as the process 
of removal of glucose from the blood stream by the 
tissues and the phosphoryl ation of this glucose. The 
second process has been termed "glucose utilizationtt , 
a nd was defined as the conversion of phosphorylated 
gluco se to glycogen, carbon dioxide, water , and lactic 
a cid. The basis for this suggested separation was the 
finding that these two processes, e lucose upt ake and 
glucose utilization , were capable of varying inde_endently 
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of each other in vitro. 
In the intact organism, it is difficult to 
measure these two proces ::;e :3 independently, and the 
method used has been to measure the A-V differences in 
blood glucose . By the standards set in the above defi-
nitions this is a measure of glucose uptake. It may be 
called glucose utilization only by assuming that the 
glucose utilization, as defined above, varies directly 
with the glucose uptake. This assumption is felt to be 
false in view of the observation reported herein that, 
at least in the presence of epinephrine, the glucose 
utilization of the isolated rat diaphragm may vary 
independently from the glucose uptake . In addition, 
it has been pointed out in the literature (32) that 
the methods for determining the blood glucose concen-
tration are of such a low order of accuracy , that the 
error in determination alone may be suffic ient to shovv 
t:.he A- V differences to go up, down or stay the same. 
It is believed that this factor may explain the di-
vergent views expressed in the literature regarding 
the action of epinephrine on glucose uptake in vivo . 
Furthermore , part of the effect seen in vivo may be 
due to the action of insulin and adrenocortical hormones. 
The observations reported her-e i n , on the in-
fluence of epinephrine on the isolat ed rat diaplragm 
125 
demon ·trated that the rate of glucose uptake increased 
slightly but sigTlificantly . In addition, the :cc.rce of 
glucose utilization decreased . It has been shown that 
this de crease in glucose uti lizati on by the isolated 
muscle was at the expense of glycogen synthesis . There -
fore, despite the decrease in ov~rall glucose utili-
zation , there was still ~n increa~e in the amount of 
glucose oxid ized . The isolated rat diaphragm exhibited 
an R. n . of l. 0 during the first hour of incubaJc ion with 
epinephrine. During the second hour , the a . ~ . was 
f'ound to .rise above l. 0 and was taken to indicate the 
conversion of carbohydrate to fat . The isolated rat 
d i aphragm has previously been observed to convert 
carbohydrate to fat (20a) . 
If the author can be permitted to speculate 
on an explanation for the respoDses in inte.ct animals 
by the observations made in isolated tissue preparations, 
it may be s aid t hat the primary or early eff ect of in-
jected epi nephrine is an induced hyperglycemia by means 
of an increased l i ver glycogenolysis . This increased 
blood glucose is ,.., ic ked up by the muscles at an increased 
rate . Once the glucose is phosphorylated by the muscles, 
less is converted to glyco gen then wo uld be i f the hyper-
g lycemia was due to other reasons than epinephri ne in-
j e ct i on . On the other hand , there is an increase in 
l2p 
g lycoly;:;is as a result of epinephri ne injection causi ng 
a lacticacidemia . This increase i n glycolysis is not 
sufficient to bal ance the decrease i n glycogen synthesis 
and the resu l t i s a storage of in·cerrnediate; probably 
hexosernonophosphate . Emphasis should be p laced on the 
statement that these suggested me chani sms in the intact 
animal are the primary or early effects of epinephrine . 
In the i nt act animal, the presen ce of a hyperglycemi a 
would result in a secret i on of insulin . Therefore the 
' 
later res ponses followi ng epi nephri ne injection would 
be the result of the combi ned a ctions of e pi nephri ne , 
insulin , and adrenocort ical hormone . 
A number of adr energic bl o ck i n g drugs belong-
i ng to a seri es of ethly horno l ogues of Aryl- 2- halo-
alkylam i nes have been synthesi zed re cent l y v-rhich are 
capable of inhi biti ng most of the excitatory effects of 
epinephrine . The data reported herein , demonstrated 
that most of these drugs vwre effect i ve in inhibiting 
t he hyperglycemic act i on of epinephri ne in the rabb i t . 
Furthermore , it 1as been suggested that the effective-
ness of these agents , a"'c l east i n the rabb i "'c , roughly 
paralle ls their pot ency as i nhib i to rs of ot her exc itat ory 
e f fe cts of ep i nephr ine . If the struc t ures of some of 
t h e more potent adrenergic blocking drugs are changed , 
by replacing t he halogen wi-t h an hydr oxyl group , or by 
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converting the ethyl homologue to a methyl homologue, 
the resulting compounds lose or have a reduced adrenergic 
blocking activity. Such compounds were also unable to 
block ep inephrine-induced hyperglycemia. 
When these agents were injected into dogs, the 
hyperglycemia induced by an infusion of epinephrine was 
reduced. However, they failed to reduce the lactic-
acidemia induced by epinephrine. In view of the finding 
that one of these agents, SY-2l,reduced the glycolysis 
induced by epinephrine in the isolated rat diaphragm, 
at the risk of transferring from in viti~ experiments 
with one species to in vivo experiments of another, it is 
suggested that the failure to reduce lacticacidemia in 
the dog was not due to a failure to inhibit muscle 
glycolysis. It has been suggested t hat the lacticacidemia 
following SY-21 and epinephrine is due to a circulatory 
accumulation of lactic acid . I n the prese nce of an 
adrenergic blocking dru g in the dose used (2 mg . of SY-21 
per kg .) epinephr ine causes a decrease in blood pressure, 
and presumably a pooling of blood. Under such conditions, 
although the actucl.l amount of lactic acid entering the 
blood stream might be decreased , it would not be carried 
to the liver as fast as it. would if the blocking drug 
were not present. Therefore, measurement of a given 
ali quot of blood would show a lacticacidemia that was not 
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. due to muscle glycolysis . 
SY- 21 was found to completely inhibit all of 
the eff ects of epinephrine on carbohydrate liletabo lisrn 
whic h were measured in the isolated rat diaphragm. On 
the other hand it only partially inhibited the glyco-
genolysis induced in the isolated rat liver slice by 
ep i nephri ne . Hence , since the p rimary a ction of ep i-
nephri ne in producing an hyperglycemia is to induce 
liver glycogenolysis, one l.·muld expect to f ind only a 
po.rtial reduction of epinephrine-induced hyperglycemia 
Vlith SY-21. This v.ras found to be the ca~)e in both the 
rabbit and the dog. 
Dihydroergocornine vms found to block f.::!pi-
nephrine - induced hyperglycemia in 'che rabbit, but was 
without effect in the dog. The reason for this failure 
in the dog is believed to be i nsuff i cient do sage . Dogs 
were unable to tolerate do::;es highe r than 0 . 05 mg ./kg . 
wj_t hout retching and vomiting. In the studies on the 
surviving tissues of the rat, it 'l'i<'LS found that DH0-180 
produced a complete inhibition of liver glycogenolysis 
induced by ep inephrine, but only a suggestion of i n -
hibition of t he effects of epinephrine on carbohydrate 
metabolism i n the diaphragm. Fur"chermore, DH0 -180 , 
itself, reduced the glycog en synthesis and increased 
the oxygen uptake of the ·diaphragm, so that i ts effect 
12_9 
sumoed with the reduced effect of epinephrine to give 
final values similar to that pro&1ced by epinephrine 
in an ot.herwise untreated diaphragm. Be cause of the 
complete inhibition seen in the isolated liver studies, 
it is not surprising that DH0-180 produced a complete 
suppression of hyperglycemia in the intact rabbit. 
Since several antihistamines can infl uence the 
pressor effects of epinephrine (76, 77), several of 
these agents were tested for their ability to influence 
epinephrine-induced hyperglycemia in the rabbit. The 
ability of these agents to inhibit the rise in blood 
sugar due to epinephrine in the rabbit paralleled their 
ability to inhibit the action of histamine on the bronch-
ioles and intestine of the guinea pig • . Since large doses 
of aminophylline did not reduce the hyperglycemifl, it 
is suggested that the effectiveness of some of these 
agents was not related to their ethylenediamine structure. 
The effectivensss of some of t hese agent s does not appear 
t.o be related to their atropine-like or local anesthetic 
pro perties since atropine, cocaine, and procaine were un-
able to inhibit epinephrine-induced hyperglycemia. On the 
other hand, Pitressin, Pitocin, and ephedrine did reduce 
the rise in blood sugar induced by epinephrine. In vievl of 
this, it is suggested that the antihistamines, in the 
presence of epinephrine, perhaps act through some circulatory 
130 
changes which influence carbohydrate mt.!tabolism onl in-
directly . 
In dogs , of three antihi::;tamines tested only 
Chlorothen r·educed epinephri ne-i nduced 1yperglycernia , 
but did not influence the l a cticacidemia . On the other 
hand, Histadyl and Chlortrimeton, 1-vhich blocked the 
blood sugar rise in the rabbit , potent i ated the hyper-
glycemia in the dog . Furthermore , Neoanterga 1, one of 
t he most potent i nhibitors of epi nephrine-indu ced 
hyperglycemia in the rabbit , did not influence the 
effects of epinephri ne on carbohydrat e metabolism i n 
the isolated rat liver and di aphr a gm . These obser -
vations together wi th those reported in the lite· ature 
suggest that the ability of the ant i histamines to i n-
hibit epinephrine-induced hyperglycemia i n th8 rabbit 
is spe cies speci f i c . 
It is conclud~d ihat it is a general property 
of the more potent adrenergic blocking drugs to inhibit 
e)inephri ne-indu ced hypergl ycemia in s~::veral mummalian 
spt:Jcies . This property exists both in vivo and in vitro . 
Since ti1ese agents by themselves do not cause hypo-
glycemia in vivo or reduce gl ycogenolysis or glycolyt>is 
in vitro , it is suogested that their mechanism of ~ction 
is to bl ock the effect of epinephrine ruther than in-
fluenc i ng carbohydrate metabolism dire ctly . Therefore , 
131 
these a gents rnake conveni ent research tools for the 
study of carbohydrate metabolism. Through their use, 
it is poss ible to study the influence of a variety of 
substances on ca r bohydrat e me tabolism ~ithout the 
complicating presence of epinephrine influences. 
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Abstract 
Under condit ions of genera l body stress , t he 
adrena l me dulla is called upon to secrete i ts hormone , 
epinephri ne. As a result of the influences of this 
hormone , a variety of changes i n the r8st i ng , hysiology 
of t he organism are incurred, which usually aid the in-
dividual in meeting the stressful challenge. Oue of the 
first change s which is known t o occur as a result of 
the a ction of endogenous or exogenous epinephrine is a 
generalized hyperglycemia . Although thi~ fundamental 
observati on has been knmvn f or half a century, a com-
plete understanding of the mechanism of a ction is still 
lacking . In the fas ting animal, it could l ogi cally 
result from an increased liver glycogenolysis and/o r a 
de creased gluco se uptake by the tissues. A revievv of 
the literature has shown that whereas all workers are 
agreed on an increased liver glycogenolys i s as a r esult 
of epinephrine a ctivity, they are f a r from agreement on 
the latter phase, the glucose uptake . The results of 
t his study indicate t hat much of the confusion is due 
to a misuse of terms , for it has been demonstrated that, 
a t least in vitro , the glucose uptake of muscle tissue 
increases, while t he amount of glucose uti lized decreases 
following epinephri ne . The extra glucose is stored in 
l 
the form of hexosemonophosphate. 
'rhe re have recently been made available a number 
of compounds belonging to the aryl~2-haloalkylamine 
series, of which Dibenamine is a type compound , which 
have the ability to i nhibit many of the a ct ions of 
exogenous or endogenous e pinephrine. For this reason, 
they are known as adrenergi c blocking drugs. It wa s of 
int erest to study a number of these compounds to deter-
mine their ability to inhibit epinephrind-induced 
hyperglycemia. .tJ. standard intravenous dose of 4 garnlni.l/kg . 
Wi.l S used as the challenging dose of epinephrine on the 
basis of a dose- response curve and the previous report 
that it was within physiologic runge . The follm'ling 
compounds were tested. They are listed by t he aryl 
portion of the molecules: 2-orthobenzyl phenoxyethyl; 
1-phenyl-2-N-methylbenzyl; 9- fluorenyl; 1-naphthylmet hyl ; 
methylthionaphthalene; 2-biphenylyloxy; benzhydryl; and 
one dihydrogenated derivative of ergot, dihydroergoc ornine. 
It is suggested tha t t he effectiveness of 2-haloalkylamines 
in diminishing or blocking epinephrine-induced hyperglycemia 
in rabbits is rough ly related to Jcheir potency us measured 
by antagonism of t he other effects of e pinephrine. The 
basis of this suggestion is that the most otent drugs 
block or diminish the blood sugar rise in u dose of 
2 ~g . /kg ., whi l e the less potent homologues require a 
2 
dose of 5 mg . /kg . t o obtain t he same eff ect. The least 
potent of t he se a gents did not reduce the hyperglycemia 
even in a dose of 10 mg ./kg . In addition , the methyl 
homologue of one of the adrenergi c block ing drugs is 
knov.;rn tu have a mar kedly reduced epinephrine antagonism, 
and did not have <:tny effect on the hyperglycemi a . Li ke -
wise , vrhen the halogen is replaced by an hydroxyl r adical, 
and the resulting a gent loses its epinephrL1e reversal 
a ction , it also los es its abili ty to block ep inephrine-
induced hyperglycemia. A review of the litera'cure , t o-
e;ether v1ith the data obtained , seems to i ndicate "chat it 
is a gen8ral property of the adrerwrgic blocking drugs 
to i nhibit the hyperglycemic effect of epinephrine in 
the rabbit. Also, it is to be expected tha t l~rger 
doses of block i ng drug are re quired -co inhibit 
e pinephrine- induced hyperglycemi a than epi nephri ne -
induced hypertension . The h ypertens i ve action of 
e 1. inephrine i s due to an algebraic s wm:-krtion of a 
pressor and depressor phase . Hen ce , a sli ght inhi-
bition of t he pres sor response becomes magnified by the 
depressor action . I-Imvever, in the glycemic effect of 
epinephrine , only a hype r gly cemic phase is present , and 
woul d require larger doses of blocking drug to induce 
an equivalent diminution to th at found in the blood 
pressure response. 
Cert a i n of the. ava i l able synthetic antihista-
minic drugs are known t o i ncrease or de crease some of 
the effects of ep inephrine. Nevertheles~ , they have 
been generally regarded a s fairly spec ific for thei r 
blockin~ action of h i stamine . A number of these agents 
were studied to determine their effect on epinephrine-
induced hyperglycemia in rabbits. The same challenging 
dos of 4 gamma/kg . in j ected i ntravenously was used . 
vfuen the antihi stamines were inj ected intravenously and 
s l owly , ·chey did not produce any rise in the blood sugar 
leve l of fasting rabbits . The f ollovdng compounds have 
been described as be i ng among the mos t potent anti-
histami ne s when t he effects of histarnine on br onchioles 
und intestines of guinea p i g s were used as test objects: 
Thenylpyramine (Histadyl) ; Chlorothen; Pyrc.:uisamine 
( Neoante r gun ) ; Tripe l enarnine (Pyribenz amine ); Phenergan ; 
Chlo rprophenpyridamine (Chlortrimeton); and 1-(10 - a cridyl) -
2 - cl imethylamino ethane. HCl. These were a l so fo und to be 
mos t effective in diminishi ng e pinephrine-indu ced hyper-
g lycemia in rabbits. It is believed that t his act ivity 
is not due t o the ethylenediamine s tructure whi ch is 
present i n most of these compounds, since two a ctive 
compounds t ested did not have this structure. In addition, 
aminophylline was ineffective even v..rhen i n j ected in 
amount s represent ing at least twice a s mu ch et hyl enediami ne 
4. 
a;:; contained in an Gffec.tive dose of a:nt i h i stamines 
of the ethylenedie:unine t ype . Fur·chermore , Letha-
p heneline ( Di atrin ) and Thonzyl amine ( Jeohetr;;un ine ) 
v-,rhich do cont a i n t he ethyl enedi amine ;:;tructure, did no t 
markedly inhi bit the hyper gl y cemia. \. number of o t her 
compounds 1.'lere tested v·Thich have been reported to have 
only 1reak antih istarni nic a ctivity, cmd these age nts 
had only a very 1ve ak i nhibiting nction . It i s unlikely; 
that the activity of these compounds is related to thei r 
local anest hetic propertieo, since cocaine and procaine 
d i d no t influence epinephrine - induced hyperglyc~nia . 
In addition , the find ing t hat a. trop i ne vfas ineffeeti ve , 
rak es it unli kely that the activity is re l a t ed to the 
a tro pine - lik e a ction of so me of these cornpou 1ds . Hovv-
ever it is notevmrt h y that Pitressin , Pitocin , and 
e phedri11e were a ll efi"ecti ve in :t"'educing th e hypex·-
glycemia. .Since these t hree a gents all p roduce vaso -
constriction and other circulatory c hanges , it suggests 
that an i nterference in the di strib ution of hype r glycemia 
due t o a redistribution of blood , or so me other such 
circulatory change influencing c arbohydrat e metabolism 
i nd irectly, may be t he 1::e c 'wnise: o f a ction of some of 
t he ant i histamines . 
.L:Jp ine~ hrine was i lf'used ilYcravenously i nt o 
trained, unanesthetized do g s and the effect of I-Ii::; 'cadyl 
5. 
a nd Chlortrimeton on the . resulting hyperglycemi a and 
lactica cidemia was examined . Interestingly, these 
agent s , most notent in rabb i ts , were without effect in 
dogs; indeed, they potent i ated the maximum r i se in blo od 
sugar . Chlorothen, however, did significantly reduce 
the hyperglycemi a , a lthough none of these agents reduced 
the lacticacidemi a . The adrenergi c b l ocking drugs N- 9-
fluo r enyl and 1-phenyl - 2- N- ruethyl of the 2-haloalkyL:tmine 
series were a lso tested in dogs a nd found to reduce the 
hy~erglycemia , al though they did not inf luence the 
l a cti cacidemia. Dihydroergocornine was \vithout effect 
in do gs , but this i s be l i ev ed to be a dosage effect. 
Finally, the effect of a d8r ivative of ergot, 
dihydroergocornine (DH0-180 ), a member of the aryl-2-
haloalkyl amine series , N-9-fluorenyl ( SY-21), and an 
antihist·· raine , "yranisamine (Neoantergan ) were tested 
for t heir ability t o influence epinephrine-induced 
effects on carbohydrate metabolism in vitro . A standard 
I' 
concent rat i on of 1. 6 X 10-o M of !-epinephrine was 
selec ted as the cha l lenging dose f or use with the is o-
lated di aphr agm and liver slice of t he rat . In the 
muscle tissue, ep i nephrine was f ound to increase the 
oxygen utilization and the amount of glucose uptake; how-
ever , the amount of glycogen synthesized and glucose uti-
l i zed was de creased . I n the liver slice , epinephr i n e c aused 
6 
an increase iri glycogenolys is and oxygen utilization. 
SY- 21 was f ound to completely block the infl uence of 
e i nephrine on mus cle, whereas it only partial l y in-
hibited the effect in liver tissue. This suggests an 
expl a nation for t h e partial i nhib i tion of the hyper-
glycemia in rabbits, since only a part i al reduc t ion 
in liver glyco genolysis would only result in a 
partia l reduction of the hyperglycemia. 
Since SY-21 compl etely inhibited the glycolysis 
induced by epinephrine i n the i solc1ted r a t diaphragm , 
it is s uggested that t he f ailure of thi s drug to reduce 
the lacticacidemia i n the dog wa s not due to a failure 
to inhibit . lycolysis. SY-21, in the presence of epi -
ne brine causes a dro p in blood pressure and pre sumably 
blood f low . Therefore , i t is possible that lactic acid 
would be a ccumulated in the blood stream, and measurements 
of a g iven ali quot of blood \•rou ld r evea l a high l a ctic 
c.1.c id concentration a lthough t he rate of muscle glycolysis 
was not elevated. 
Con·c r a ry to the effects of SY- 21 , vv-ere the 
effects. of DH0 - 180 whi ch exhibited only a partial in-
hibition of the effects in muscle, but a complete i n -
.hib ition of the effects i n liver. Hence, it is to be 
expected, as was found, that in vivo this agent would 
produce a complete inhibition of epinephrine-induced 
7. 
hyperglycemia . 
Neoantergan was without activity when added to 
·the surviving r o.t diaphragm and liver even in high 
concentration . This f i nding, together with those in 
the intact dog, suggest that the ability of the anti-
h istainines to inhibit epinephrine-induced hyperglycemia 
in the rabbit is species specific. 
It is concluded that epinephrine induces its 
hyperglycemic action primarily through an increased 
liver glycogenolysis. A general property of the more 
potent adrenergic blocking drugs is to inhibit 
epinephrine-induced hyperglycemia in several ma1mnalian 
species. This property exists both i n vitro and in vivo. 
Their mechanism of action is believed to be a blockade 
of the effect of epinephrine rCLth er than any direct 
effect on c<:• rb'ohydrate metabolism. 
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